id	sid	tid	token	lemma	pos
gra-1415	1	1	introduction	introduction	NOUN
gra-1415	1	2	hypertension	hypertension	NOUN
gra-1415	1	3	is	be	AUX
gra-1415	1	4	more	more	ADV
gra-1415	1	5	prevalent	prevalent	ADJ
gra-1415	1	6	in	in	ADP
gra-1415	1	7	patients	patient	NOUN
gra-1415	1	8	with	with	ADP
gra-1415	1	9	chronic	chronic	ADJ
gra-1415	1	10	kidney	kidney	NOUN
gra-1415	1	11	disease	disease	NOUN
gra-1415	1	12	(	(	PUNCT
gra-1415	1	13	ckd	ckd	NOUN
gra-1415	1	14	)	)	PUNCT
gra-1415	1	15	and	and	CCONJ
gra-1415	1	16	has	have	VERB
gra-1415	1	17	a	a	DET
gra-1415	1	18	strong	strong	ADJ
gra-1415	1	19	risk	risk	NOUN
gra-1415	1	20	of	of	ADP
gra-1415	1	21	cardiovascular	cardiovascular	ADJ
gra-1415	1	22	disease	disease	NOUN
gra-1415	1	23	.	.	PUNCT
gra-1415	2	1	elevated	elevated	ADJ
gra-1415	2	2	blood	blood	NOUN
gra-1415	2	3	pressure	pressure	NOUN
gra-1415	2	4	leads	lead	VERB
gra-1415	2	5	to	to	PART
gra-1415	2	6	decline	decline	VERB
gra-1415	2	7	the	the	DET
gra-1415	2	8	kidney	kidney	NOUN
gra-1415	2	9	function	function	NOUN
gra-1415	2	10	in	in	ADP
gra-1415	2	11	ckd	ckd	PROPN
gra-1415	2	12	patients	patient	NOUN
gra-1415	2	13	.	.	PUNCT
gra-1415	3	1	therefore	therefore	ADV
gra-1415	3	2	,	,	PUNCT
gra-1415	3	3	treatment	treatment	NOUN
gra-1415	3	4	of	of	ADP
gra-1415	3	5	hypertension	hypertension	NOUN
gra-1415	3	6	plays	play	VERB
gra-1415	3	7	a	a	DET
gra-1415	3	8	central	central	ADJ
gra-1415	3	9	role	role	NOUN
gra-1415	3	10	in	in	ADP
gra-1415	3	11	the	the	DET
gra-1415	3	12	management	management	NOUN
gra-1415	3	13	of	of	ADP
gra-1415	3	14	ckd	ckd	PROPN
gra-1415	3	15	.	.	PUNCT
gra-1415	4	1	hypertension	hypertension	NOUN
gra-1415	4	2	accelerates	accelerate	VERB
gra-1415	4	3	vascular	vascular	ADJ
gra-1415	4	4	aging	aging	NOUN
gra-1415	4	5	which	which	PRON
gra-1415	4	6	leads	lead	VERB
gra-1415	4	7	to	to	ADP
gra-1415	4	8	aortic	aortic	ADJ
gra-1415	4	9	stiffening	stiffening	NOUN
gra-1415	4	10	.	.	PUNCT
gra-1415	5	1	increased	increase	VERB
gra-1415	5	2	arterial	arterial	ADJ
gra-1415	5	3	stiffness	stiffness	NOUN
gra-1415	5	4	(	(	PUNCT
gra-1415	5	5	pulse	pulse	NOUN
gra-1415	5	6	wave	wave	NOUN
gra-1415	5	7	velocity	velocity	NOUN
gra-1415	6	1	[	[	X
gra-1415	6	2	pwv	pwv	NOUN
gra-1415	6	3	]	]	PUNCT
gra-1415	6	4	)	)	PUNCT
gra-1415	6	5	is	be	AUX
gra-1415	6	6	associated	associate	VERB
gra-1415	6	7	with	with	ADP
gra-1415	6	8	increased	increase	VERB
gra-1415	6	9	systolic	systolic	ADJ
gra-1415	6	10	blood	blood	NOUN
gra-1415	6	11	pressure	pressure	NOUN
gra-1415	6	12	(	(	PUNCT
gra-1415	6	13	sbp	sbp	NOUN
gra-1415	6	14	)	)	PUNCT
gra-1415	6	15	.	.	PUNCT
gra-1415	7	1	however	however	ADV
gra-1415	7	2	antihypertensive	antihypertensive	ADJ
gra-1415	7	3	drug	drug	NOUN
gra-1415	7	4	has	have	AUX
gra-1415	7	5	achieved	achieve	VERB
gra-1415	7	6	better	well	ADJ
gra-1415	7	7	controlling	control	VERB
gra-1415	7	8	effect	effect	NOUN
gra-1415	7	9	on	on	ADP
gra-1415	7	10	diastolic	diastolic	ADJ
gra-1415	7	11	blood	blood	NOUN
gra-1415	7	12	pressure	pressure	NOUN
gra-1415	7	13	(	(	PUNCT
gra-1415	7	14	dbp	dbp	PROPN
gra-1415	7	15	)	)	PUNCT
gra-1415	7	16	than	than	ADP
gra-1415	7	17	sbp	sbp	PROPN
gra-1415	7	18	.	.	PUNCT
gra-1415	8	1	pwv	pwv	PROPN
gra-1415	8	2	may	may	AUX
gra-1415	8	3	remain	remain	VERB
gra-1415	8	4	same	same	ADJ
gra-1415	8	5	or	or	CCONJ
gra-1415	8	6	not	not	PART
gra-1415	8	7	after	after	ADP
gra-1415	8	8	the	the	DET
gra-1415	8	9	antihypertensive	antihypertensive	ADJ
gra-1415	8	10	drug	drug	NOUN
gra-1415	8	11	therapy	therapy	NOUN
gra-1415	8	12	,	,	PUNCT
gra-1415	8	13	which	which	PRON
gra-1415	8	14	directly	directly	ADV
gra-1415	8	15	implies	imply	VERB
gra-1415	8	16	sbp	sbp	NOUN
gra-1415	8	17	response	response	NOUN
gra-1415	8	18	to	to	ADP
gra-1415	8	19	the	the	DET
gra-1415	8	20	treatment	treatment	NOUN
gra-1415	8	21	[	[	X
gra-1415	8	22	1	1	NUM
gra-1415	8	23	]	]	PUNCT
gra-1415	8	24	.	.	PUNCT
gra-1415	9	1	antihypertensive	antihypertensive	ADJ
gra-1415	9	2	regimens	regimen	NOUN
gra-1415	9	3	commonly	commonly	ADV
gra-1415	9	4	include	include	VERB
gra-1415	9	5	angiotensinconverting	angiotensinconverte	VERB
gra-1415	9	6	enzyme	enzyme	NOUN
gra-1415	9	7	(	(	PUNCT
gra-1415	9	8	ace	ace	NOUN
gra-1415	9	9	)	)	PUNCT
gra-1415	9	10	inhibitor	inhibitor	NOUN
gra-1415	9	11	and	and	CCONJ
gra-1415	9	12	angiotensin	angiotensin	NOUN
gra-1415	9	13	receptor	receptor	NOUN
gra-1415	9	14	blocker	blocker	NOUN
gra-1415	9	15	(	(	PUNCT
gra-1415	9	16	arb	arb	PROPN
gra-1415	9	17	)	)	PUNCT
gra-1415	9	18	,	,	PUNCT
gra-1415	9	19	calcium	calcium	NOUN
gra-1415	9	20	channel	channel	NOUN
gra-1415	9	21	blocker	blocker	NOUN
gra-1415	9	22	(	(	PUNCT
gra-1415	9	23	ccb	ccb	PROPN
gra-1415	9	24	)	)	PUNCT
gra-1415	9	25	,	,	PUNCT
gra-1415	9	26	and	and	CCONJ
gra-1415	9	27	beta	beta	ADJ
gra-1415	9	28	blockers	blocker	NOUN
gra-1415	9	29	[	[	X
gra-1415	9	30	2	2	NUM
gra-1415	9	31	]	]	PUNCT
gra-1415	9	32	.	.	PUNCT
gra-1415	10	1	the	the	DET
gra-1415	10	2	mechanism	mechanism	NOUN
gra-1415	10	3	of	of	ADP
gra-1415	10	4	action	action	NOUN
gra-1415	10	5	of	of	ADP
gra-1415	10	6	ccb	ccb	PROPN
gra-1415	10	7	,	,	PUNCT
gra-1415	10	8	including	include	VERB
gra-1415	10	9	amlodipine	amlodipine	NOUN
gra-1415	10	10	which	which	PRON
gra-1415	10	11	inhibits	inhibit	VERB
gra-1415	10	12	n	n	NUM
gra-1415	10	13	-	-	PUNCT
gra-1415	10	14	type	type	NOUN
gra-1415	10	15	calcium	calcium	NOUN
gra-1415	10	16	channel	channel	NOUN
gra-1415	10	17	and	and	CCONJ
gra-1415	10	18	cilnidipine	cilnidipine	NOUN
gra-1415	10	19	which	which	PRON
gra-1415	10	20	inhibits	inhibit	VERB
gra-1415	10	21	both	both	PRON
gra-1415	10	22	l	l	NOUN
gra-1415	10	23	and	and	CCONJ
gra-1415	10	24	n	n	CCONJ
gra-1415	10	25	-	-	PUNCT
gra-1415	10	26	type	type	NOUN
gra-1415	10	27	calcium	calcium	NOUN
gra-1415	10	28	channels	channel	NOUN
gra-1415	10	29	,	,	PUNCT
gra-1415	10	30	in	in	ADP
gra-1415	10	31	hypertension	hypertension	NOUN
gra-1415	10	32	is	be	AUX
gra-1415	10	33	due	due	ADJ
gra-1415	10	34	to	to	ADP
gra-1415	10	35	its	its	PRON
gra-1415	10	36	inhibition	inhibition	NOUN
gra-1415	10	37	of	of	ADP
gra-1415	10	38	calcium	calcium	NOUN
gra-1415	10	39	inux	inux	NOUN
gra-1415	10	40	into	into	ADP
gra-1415	10	41	vascular	vascular	ADJ
gra-1415	10	42	smooth	smooth	ADJ
gra-1415	10	43	muscle	muscle	NOUN
gra-1415	10	44	cells	cell	NOUN
gra-1415	10	45	(	(	PUNCT
gra-1415	10	46	vmc	vmc	PROPN
gra-1415	10	47	)	)	PUNCT
gra-1415	10	48	that	that	PRON
gra-1415	10	49	causes	cause	VERB
gra-1415	10	50	relaxation	relaxation	NOUN
gra-1415	10	51	of	of	ADP
gra-1415	10	52	vmc	vmc	PROPN
gra-1415	10	53	,	,	PUNCT
gra-1415	10	54	decreased	decrease	VERB
gra-1415	10	55	after	after	ADP
gra-1415	10	56	load	load	NOUN
gra-1415	10	57	and	and	CCONJ
gra-1415	10	58	systemic	systemic	ADJ
gra-1415	10	59	blood	blood	NOUN
gra-1415	10	60	pressure	pressure	NOUN
gra-1415	10	61	.	.	PUNCT
gra-1415	11	1	both	both	PRON
gra-1415	11	2	amlodipine	amlodipine	NOUN
gra-1415	11	3	and	and	CCONJ
gra-1415	11	4	cilnidipine	cilnidipine	NOUN
gra-1415	11	5	have	have	VERB
gra-1415	11	6	signicant	signicant	ADJ
gra-1415	11	7	impact	impact	NOUN
gra-1415	11	8	on	on	ADP
gra-1415	11	9	blood	blood	NOUN
gra-1415	11	10	pressure	pressure	NOUN
gra-1415	11	11	and	and	CCONJ
gra-1415	11	12	arterial	arterial	ADJ
gra-1415	11	13	stiffness	stiffness	NOUN
gra-1415	12	1	[	[	X
gra-1415	12	2	3	3	NUM
gra-1415	12	3	-	-	SYM
gra-1415	12	4	5	5	NUM
gra-1415	12	5	]	]	PUNCT
gra-1415	12	6	.	.	PUNCT
gra-1415	13	1	however	however	ADV
gra-1415	13	2	,	,	PUNCT
gra-1415	13	3	amlodipine	amlodipine	PROPN
gra-1415	13	4	associated	associate	VERB
gra-1415	13	5	with	with	ADP
gra-1415	13	6	higher	high	ADJ
gra-1415	13	7	incidence	incidence	NOUN
gra-1415	13	8	of	of	ADP
gra-1415	13	9	adverse	adverse	ADJ
gra-1415	13	10	events	event	NOUN
gra-1415	13	11	like	like	ADP
gra-1415	13	12	pedal	pedal	ADJ
gra-1415	13	13	edema	edema	NOUN
gra-1415	13	14	leads	lead	VERB
gra-1415	13	15	to	to	ADP
gra-1415	13	16	discontinuing	discontinue	VERB
gra-1415	13	17	the	the	DET
gra-1415	13	18	treatment	treatment	NOUN
gra-1415	13	19	.	.	PUNCT
gra-1415	14	1	studies	study	NOUN
gra-1415	14	2	have	have	AUX
gra-1415	14	3	reported	report	VERB
gra-1415	14	4	the	the	DET
gra-1415	14	5	similar	similar	ADJ
gra-1415	14	6	antihypertensive	antihypertensive	ADJ
gra-1415	14	7	action	action	NOUN
gra-1415	14	8	between	between	ADP
gra-1415	14	9	amlodipine	amlodipine	NOUN
gra-1415	14	10	and	and	CCONJ
gra-1415	14	11	cilnidipine	cilnidipine	ADJ
gra-1415	14	12	[	[	X
gra-1415	14	13	6	6	NUM
gra-1415	14	14	,	,	PUNCT
gra-1415	14	15	7	7	NUM
gra-1415	14	16	]	]	PUNCT
gra-1415	14	17	.	.	PUNCT
gra-1415	15	1	however	however	ADV
gra-1415	15	2	,	,	PUNCT
gra-1415	15	3	cilnidipine	cilnidipine	PROPN
gra-1415	15	4	is	be	AUX
gra-1415	15	5	superior	superior	ADJ
gra-1415	15	6	in	in	ADP
gra-1415	15	7	terms	term	NOUN
gra-1415	15	8	of	of	ADP
gra-1415	15	9	improving	improve	VERB
gra-1415	15	10	articial	articial	ADJ
gra-1415	15	11	stiffness	stiffness	NOUN
gra-1415	15	12	and	and	CCONJ
gra-1415	15	13	central	central	ADJ
gra-1415	15	14	aortic	aortic	ADJ
gra-1415	15	15	pressure	pressure	NOUN
gra-1415	15	16	[	[	X
gra-1415	15	17	8	8	NUM
gra-1415	15	18	,	,	PUNCT
gra-1415	15	19	9	9	NUM
gra-1415	15	20	]	]	PUNCT
gra-1415	15	21	with	with	ADP
gra-1415	15	22	greater	great	ADJ
gra-1415	15	23	antiproteinuric	antiproteinuric	ADJ
gra-1415	15	24	effect	effect	NOUN
gra-1415	15	25	[	[	X
gra-1415	15	26	10	10	NUM
gra-1415	15	27	,	,	PUNCT
gra-1415	15	28	11	11	NUM
gra-1415	15	29	]	]	PUNCT
gra-1415	15	30	.	.	PUNCT
gra-1415	16	1	there	there	PRON
gra-1415	16	2	is	be	VERB
gra-1415	16	3	still	still	ADV
gra-1415	16	4	a	a	DET
gra-1415	16	5	scarcity	scarcity	NOUN
gra-1415	16	6	of	of	ADP
gra-1415	16	7	clinical	clinical	ADJ
gra-1415	16	8	trials	trial	NOUN
gra-1415	16	9	comparing	compare	VERB
gra-1415	16	10	effects	effect	NOUN
gra-1415	16	11	of	of	ADP
gra-1415	16	12	amlodipine	amlodipine	NOUN
gra-1415	16	13	and	and	CCONJ
gra-1415	16	14	cilnidipine	cilnidipine	NOUN
gra-1415	16	15	on	on	ADP
gra-1415	16	16	arterial	arterial	ADJ
gra-1415	16	17	stiffness	stiffness	NOUN
gra-1415	16	18	and	and	CCONJ
gra-1415	16	19	vascular	vascular	ADJ
gra-1415	16	20	aging	aging	NOUN
gra-1415	16	21	in	in	ADP
gra-1415	16	22	patients	patient	NOUN
gra-1415	16	23	with	with	ADP
gra-1415	16	24	ckd	ckd	PROPN
gra-1415	16	25	associated	associated	ADJ
gra-1415	16	26	hypertension	hypertension	NOUN
gra-1415	16	27	.	.	PUNCT
gra-1415	17	1	therefore	therefore	ADV
gra-1415	17	2	,	,	PUNCT
gra-1415	17	3	the	the	DET
gra-1415	17	4	present	present	ADJ
gra-1415	17	5	study	study	NOUN
gra-1415	17	6	aimed	aim	VERB
gra-1415	17	7	to	to	PART
gra-1415	17	8	assess	assess	VERB
gra-1415	17	9	and	and	CCONJ
gra-1415	17	10	compare	compare	VERB
gra-1415	17	11	amlodipine	amlodipine	NOUN
gra-1415	17	12	with	with	ADP
gra-1415	17	13	cilnidipine	cilnidipine	NOUN
gra-1415	17	14	on	on	ADP
gra-1415	17	15	hemodynamic	hemodynamic	ADJ
gra-1415	17	16	parameters	parameter	NOUN
gra-1415	17	17	of	of	ADP
gra-1415	17	18	central	central	ADJ
gra-1415	17	19	blood	blood	NOUN
gra-1415	17	20	pressure	pressure	NOUN
gra-1415	17	21	and	and	CCONJ
gra-1415	17	22	arterial	arterial	ADJ
gra-1415	17	23	stiffness	stiffness	NOUN
gra-1415	17	24	in	in	ADP
gra-1415	17	25	patients	patient	NOUN
gra-1415	17	26	with	with	ADP
gra-1415	17	27	ckd	ckd	PROPN
gra-1415	17	28	on	on	ADP
gra-1415	17	29	dialysis	dialysis	NOUN
gra-1415	17	30	and	and	CCONJ
gra-1415	17	31	with	with	ADP
gra-1415	17	32	associated	associated	ADJ
gra-1415	17	33	hypertension	hypertension	NOUN
gra-1415	17	34	.	.	PUNCT
gra-1415	18	1	methods	method	NOUN
gra-1415	18	2	and	and	CCONJ
gra-1415	18	3	materials	material	NOUN
gra-1415	18	4	study	study	NOUN
gra-1415	18	5	design	design	NOUN
gra-1415	18	6	:	:	PUNCT
gra-1415	18	7	the	the	DET
gra-1415	18	8	present	present	ADJ
gra-1415	18	9	prospective	prospective	ADJ
gra-1415	18	10	study	study	NOUN
gra-1415	18	11	was	be	AUX
gra-1415	18	12	conducted	conduct	VERB
gra-1415	18	13	in	in	ADP
gra-1415	18	14	the	the	DET
gra-1415	18	15	department	department	NOUN
gra-1415	18	16	of	of	ADP
gra-1415	18	17	nephrology	nephrology	NOUN
gra-1415	18	18	of	of	ADP
gra-1415	18	19	grant	grant	NOUN
gra-1415	18	20	government	government	NOUN
gra-1415	18	21	medical	medical	PROPN
gra-1415	18	22	college	college	PROPN
gra-1415	18	23	and	and	CCONJ
gra-1415	18	24	sir	sir	PROPN
gra-1415	18	25	j.	j.	PROPN
gra-1415	18	26	j.	j.	PROPN
gra-1415	18	27	group	group	PROPN
gra-1415	18	28	of	of	ADP
gra-1415	18	29	hospitals	hospital	NOUN
gra-1415	18	30	,	,	PUNCT
gra-1415	18	31	mumbai	mumbai	PROPN
gra-1415	18	32	,	,	PUNCT
gra-1415	18	33	maharashtra	maharashtra	PROPN
gra-1415	18	34	,	,	PUNCT
gra-1415	18	35	india	india	PROPN
gra-1415	18	36	from	from	ADP
gra-1415	18	37	october	october	PROPN
gra-1415	18	38	2018	2018	NUM
gra-1415	18	39	to	to	ADP
gra-1415	18	40	october	october	PROPN
gra-1415	18	41	2019	2019	NUM
gra-1415	18	42	.	.	PUNCT
gra-1415	19	1	patients	patient	NOUN
gra-1415	19	2	of	of	ADP
gra-1415	19	3	either	either	DET
gra-1415	19	4	sex	sex	NOUN
gra-1415	19	5	with	with	ADP
gra-1415	19	6	ckd	ckd	PROPN
gra-1415	19	7	on	on	ADP
gra-1415	19	8	dialysis	dialysis	NOUN
gra-1415	19	9	and	and	CCONJ
gra-1415	19	10	with	with	ADP
gra-1415	19	11	associated	associated	ADJ
gra-1415	19	12	hypertension	hypertension	NOUN
gra-1415	19	13	were	be	AUX
gra-1415	19	14	included	include	VERB
gra-1415	19	15	in	in	ADP
gra-1415	19	16	the	the	DET
gra-1415	19	17	study	study	NOUN
gra-1415	19	18	.	.	PUNCT
gra-1415	20	1	patient	patient	ADJ
gra-1415	20	2	with	with	ADP
gra-1415	20	3	any	any	DET
gra-1415	20	4	known	know	VERB
gra-1415	20	5	drug	drug	NOUN
gra-1415	20	6	allergy	allergy	NOUN
gra-1415	20	7	,	,	PUNCT
gra-1415	20	8	or	or	CCONJ
gra-1415	20	9	with	with	ADP
gra-1415	20	10	any	any	DET
gra-1415	20	11	history	history	NOUN
gra-1415	20	12	of	of	ADP
gra-1415	20	13	systemic	systemic	ADJ
gra-1415	20	14	illness	illness	NOUN
gra-1415	20	15	and	and	CCONJ
gra-1415	20	16	presence	presence	NOUN
gra-1415	20	17	of	of	ADP
gra-1415	20	18	pre	pre	ADJ
gra-1415	20	19	-	-	ADJ
gra-1415	20	20	existing	existing	ADJ
gra-1415	20	21	edema	edema	NOUN
gra-1415	20	22	,	,	PUNCT
gra-1415	20	23	nephritic	nephritic	ADJ
gra-1415	20	24	syndrome	syndrome	NOUN
gra-1415	20	25	,	,	PUNCT
gra-1415	20	26	anaemia	anaemia	NOUN
gra-1415	20	27	was	be	AUX
gra-1415	20	28	excluded	exclude	VERB
gra-1415	20	29	from	from	ADP
gra-1415	20	30	this	this	DET
gra-1415	20	31	study	study	NOUN
gra-1415	20	32	.	.	PUNCT
gra-1415	21	1	study	study	NOUN
gra-1415	21	2	procedure	procedure	NOUN
gra-1415	21	3	:	:	PUNCT
gra-1415	21	4	the	the	DET
gra-1415	21	5	complete	complete	ADJ
gra-1415	21	6	medical	medical	ADJ
gra-1415	21	7	history	history	NOUN
gra-1415	21	8	and	and	CCONJ
gra-1415	21	9	demographic	demographic	ADJ
gra-1415	21	10	details	detail	NOUN
gra-1415	21	11	(	(	PUNCT
gra-1415	21	12	age	age	NOUN
gra-1415	21	13	,	,	PUNCT
gra-1415	21	14	sex	sex	NOUN
gra-1415	21	15	,	,	PUNCT
gra-1415	21	16	body	body	NOUN
gra-1415	21	17	mass	mass	NOUN
gra-1415	21	18	index	index	NOUN
gra-1415	21	19	(	(	PUNCT
gra-1415	21	20	bmi	bmi	PROPN
gra-1415	21	21	)	)	PUNCT
gra-1415	21	22	,	,	PUNCT
gra-1415	21	23	bp	bp	PROPN
gra-1415	21	24	)	)	PUNCT
gra-1415	21	25	were	be	AUX
gra-1415	21	26	collected	collect	VERB
gra-1415	21	27	for	for	ADP
gra-1415	21	28	each	each	DET
gra-1415	21	29	patient	patient	NOUN
gra-1415	21	30	.	.	PUNCT
gra-1415	22	1	central	central	ADJ
gra-1415	22	2	blood	blood	NOUN
gra-1415	22	3	pressure	pressure	NOUN
gra-1415	22	4	(	(	PUNCT
gra-1415	22	5	cbp	cbp	PROPN
gra-1415	22	6	)	)	PUNCT
gra-1415	22	7	and	and	CCONJ
gra-1415	22	8	as	as	SCONJ
gra-1415	22	9	were	be	AUX
gra-1415	22	10	measured	measure	VERB
gra-1415	22	11	®	®	NOUN
gra-1415	22	12	using	use	VERB
gra-1415	22	13	the	the	DET
gra-1415	22	14	mobil	mobil	NOUN
gra-1415	22	15	-	-	PUNCT
gra-1415	22	16	o	o	NOUN
gra-1415	22	17	-	-	NOUN
gra-1415	22	18	graph	graph	NOUN
gra-1415	22	19	pwa	pwa	PROPN
gra-1415	22	20	(	(	PUNCT
gra-1415	22	21	i.e.m	i.e.m	NOUN
gra-1415	22	22	.	.	PUNCT
gra-1415	22	23	gmbh	gmbh	PROPN
gra-1415	22	24	,	,	PUNCT
gra-1415	22	25	stolberg	stolberg	PROPN
gra-1415	22	26	,	,	PUNCT
gra-1415	22	27	germany	germany	PROPN
gra-1415	22	28	)	)	PUNCT
gra-1415	22	29	.	.	PUNCT
gra-1415	23	1	a	a	DET
gra-1415	23	2	common	common	ADJ
gra-1415	23	3	cuff	cuff	NOUN
gra-1415	23	4	was	be	AUX
gra-1415	23	5	centered	center	VERB
gra-1415	23	6	on	on	ADP
gra-1415	23	7	the	the	DET
gra-1415	23	8	left	left	ADJ
gra-1415	23	9	upper	upper	ADJ
gra-1415	23	10	arm	arm	NOUN
gra-1415	23	11	.	.	PUNCT
gra-1415	24	1	cuff	cuff	NOUN
gra-1415	24	2	size	size	NOUN
gra-1415	24	3	was	be	AUX
gra-1415	24	4	chosen	choose	VERB
gra-1415	24	5	according	accord	VERB
gra-1415	24	6	to	to	ADP
gra-1415	24	7	the	the	DET
gra-1415	24	8	circumference	circumference	NOUN
gra-1415	24	9	of	of	ADP
gra-1415	24	10	the	the	DET
gra-1415	24	11	®	®	NOUN
gra-1415	24	12	mid	mid	ADJ
gra-1415	24	13	-	-	ADJ
gra-1415	24	14	upper	upper	ADJ
gra-1415	24	15	arm	arm	NOUN
gra-1415	24	16	.	.	PUNCT
gra-1415	25	1	mobil	mobil	PROPN
gra-1415	25	2	-	-	PUNCT
gra-1415	25	3	o	o	NOUN
gra-1415	25	4	-	-	NOUN
gra-1415	25	5	graph	graph	NOUN
gra-1415	25	6	pwa	pwa	PROPN
gra-1415	25	7	provides	provide	VERB
gra-1415	25	8	information	information	NOUN
gra-1415	25	9	about	about	ADP
gra-1415	25	10	peripheral	peripheral	ADJ
gra-1415	25	11	bp	bp	PROPN
gra-1415	25	12	,	,	PUNCT
gra-1415	25	13	vascular	vascular	ADJ
gra-1415	25	14	age	age	NOUN
gra-1415	25	15	,	,	PUNCT
gra-1415	25	16	augmentation	augmentation	NOUN
gra-1415	25	17	index	index	NOUN
gra-1415	25	18	(	(	PUNCT
gra-1415	25	19	ai	ai	NOUN
gra-1415	25	20	)	)	PUNCT
gra-1415	25	21	and	and	CCONJ
gra-1415	25	22	pwv	pwv	PROPN
gra-1415	25	23	.	.	PUNCT
gra-1415	26	1	patients	patient	NOUN
gra-1415	26	2	who	who	PRON
gra-1415	26	3	were	be	AUX
gra-1415	26	4	taking	take	VERB
gra-1415	26	5	either	either	CCONJ
gra-1415	26	6	amlodipine	amlodipine	NOUN
gra-1415	26	7	or	or	CCONJ
gra-1415	26	8	cilnidipine	cilnidipine	NOUN
gra-1415	26	9	were	be	AUX
gra-1415	26	10	categorised	categorise	VERB
gra-1415	26	11	into	into	ADP
gra-1415	26	12	group	group	NOUN
gra-1415	26	13	1	1	NUM
gra-1415	26	14	and	and	CCONJ
gra-1415	26	15	group	group	NOUN
gra-1415	26	16	2	2	NUM
gra-1415	26	17	,	,	PUNCT
gra-1415	26	18	respectively	respectively	ADV
gra-1415	26	19	.	.	PUNCT
gra-1415	27	1	bp	bp	PROPN
gra-1415	27	2	and	and	CCONJ
gra-1415	27	3	pulse	pulse	NOUN
gra-1415	27	4	rate	rate	NOUN
gra-1415	27	5	value	value	NOUN
gra-1415	27	6	were	be	AUX
gra-1415	27	7	analysed	analyse	VERB
gra-1415	27	8	and	and	CCONJ
gra-1415	27	9	the	the	DET
gra-1415	27	10	average	average	ADJ
gra-1415	27	11	value	value	NOUN
gra-1415	27	12	was	be	AUX
gra-1415	27	13	recorded	record	VERB
gra-1415	27	14	.	.	PUNCT
gra-1415	28	1	statistical	statistical	ADJ
gra-1415	28	2	analysis	analysis	NOUN
gra-1415	28	3	:	:	PUNCT
gra-1415	28	4	statistical	statistical	ADJ
gra-1415	28	5	analysis	analysis	NOUN
gra-1415	28	6	was	be	AUX
gra-1415	28	7	performed	perform	VERB
gra-1415	28	8	using	use	VERB
gra-1415	28	9	statistical	statistical	ADJ
gra-1415	28	10	package	package	NOUN
gra-1415	28	11	for	for	ADP
gra-1415	28	12	the	the	DET
gra-1415	28	13	social	social	ADJ
gra-1415	28	14	sciences	sciences	PROPN
gra-1415	28	15	(	(	PUNCT
gra-1415	28	16	spss	spss	PROPN
gra-1415	28	17	)	)	PUNCT
gra-1415	28	18	version	version	NOUN
gra-1415	28	19	23.0	23.0	NUM
gra-1415	28	20	.	.	PUNCT
gra-1415	29	1	analysis	analysis	NOUN
gra-1415	29	2	of	of	ADP
gra-1415	29	3	categorical	categorical	ADJ
gra-1415	29	4	variables	variable	NOUN
gra-1415	29	5	using	use	VERB
gra-1415	29	6	chi	chi	ADJ
gra-1415	29	7	-	-	PUNCT
gra-1415	29	8	square	square	NOUN
gra-1415	29	9	test	test	NOUN
gra-1415	29	10	and	and	CCONJ
gra-1415	29	11	continuous	continuous	ADJ
gra-1415	29	12	variables	variable	NOUN
gra-1415	29	13	using	use	VERB
gra-1415	29	14	independent	independent	ADJ
gra-1415	29	15	sample	sample	NOUN
gra-1415	29	16	t	t	PROPN
gra-1415	29	17	-	-	PUNCT
gra-1415	29	18	test	test	NOUN
gra-1415	29	19	was	be	AUX
gra-1415	29	20	done	do	VERB
gra-1415	29	21	for	for	ADP
gra-1415	29	22	the	the	DET
gra-1415	29	23	assessment	assessment	NOUN
gra-1415	29	24	of	of	ADP
gra-1415	29	25	the	the	DET
gra-1415	29	26	level	level	NOUN
gra-1415	29	27	of	of	ADP
gra-1415	29	28	signicance	signicance	NOUN
gra-1415	29	29	.	.	PUNCT
gra-1415	30	1	a	a	DET
gra-1415	30	2	p	p	NOUN
gra-1415	30	3	value	value	NOUN
gra-1415	30	4	<	<	NOUN
gra-1415	30	5	0.05	0.05	NUM
gra-1415	30	6	was	be	AUX
gra-1415	30	7	considered	consider	VERB
gra-1415	30	8	statistically	statistically	ADV
gra-1415	30	9	signicant	signicant	ADJ
gra-1415	30	10	.	.	PUNCT
gra-1415	31	1	results	result	VERB
gra-1415	31	2	a	a	DET
gra-1415	31	3	total	total	NOUN
gra-1415	31	4	of	of	ADP
gra-1415	31	5	87	87	NUM
gra-1415	31	6	patients	patient	NOUN
gra-1415	31	7	were	be	AUX
gra-1415	31	8	included	include	VERB
gra-1415	31	9	and	and	CCONJ
gra-1415	31	10	majority	majority	NOUN
gra-1415	31	11	of	of	ADP
gra-1415	31	12	patients	patient	NOUN
gra-1415	31	13	were	be	AUX
gra-1415	31	14	men	man	NOUN
gra-1415	31	15	(	(	PUNCT
gra-1415	31	16	n=55	n=55	ADV
gra-1415	31	17	)	)	PUNCT
gra-1415	31	18	.	.	PUNCT
gra-1415	32	1	the	the	DET
gra-1415	32	2	demographics	demographic	NOUN
gra-1415	32	3	of	of	ADP
gra-1415	32	4	enrolled	enrol	VERB
gra-1415	32	5	patients	patient	NOUN
gra-1415	32	6	are	be	AUX
gra-1415	32	7	summarized	summarize	VERB
gra-1415	32	8	in	in	ADP
gra-1415	32	9	table	table	NOUN
gra-1415	32	10	1	1	NUM
gra-1415	32	11	.	.	PUNCT
gra-1415	32	12	comparison	comparison	NOUN
gra-1415	32	13	of	of	ADP
gra-1415	32	14	hemodynamic	hemodynamic	ADJ
gra-1415	32	15	and	and	CCONJ
gra-1415	32	16	vascular	vascular	ADJ
gra-1415	32	17	parameters	parameter	NOUN
gra-1415	32	18	between	between	ADP
gra-1415	32	19	patients	patient	NOUN
gra-1415	32	20	with	with	ADP
gra-1415	32	21	ckd	ckd	PROPN
gra-1415	32	22	and	and	CCONJ
gra-1415	32	23	associated	associated	ADJ
gra-1415	32	24	hypertension	hypertension	NOUN
gra-1415	32	25	treated	treat	VERB
gra-1415	32	26	with	with	ADP
gra-1415	32	27	amlodipine	amlodipine	ADJ
gra-1415	32	28	and	and	CCONJ
gra-1415	32	29	cilnidipine	cilnidipine	ADJ
gra-1415	32	30	original	original	ADJ
gra-1415	32	31	research	research	NOUN
gra-1415	32	32	paper	paper	PROPN
gra-1415	32	33	dr	dr	PROPN
gra-1415	32	34	.	.	PROPN
gra-1415	32	35	geeta	geeta	PROPN
gra-1415	32	36	sheth	sheth	PROPN
gra-1415	32	37	*	*	PROPN
gra-1415	32	38	associate	associate	PROPN
gra-1415	32	39	professor	professor	NOUN
gra-1415	32	40	,	,	PUNCT
gra-1415	32	41	department	department	NOUN
gra-1415	32	42	of	of	ADP
gra-1415	32	43	nephrology	nephrology	NOUN
gra-1415	32	44	,	,	PUNCT
gra-1415	32	45	grant	grant	VERB
gra-1415	32	46	government	government	NOUN
gra-1415	32	47	medical	medical	PROPN
gra-1415	32	48	college	college	PROPN
gra-1415	32	49	and	and	CCONJ
gra-1415	32	50	sir	sir	PROPN
gra-1415	32	51	j.	j.	PROPN
gra-1415	32	52	j.	j.	PROPN
gra-1415	32	53	group	group	PROPN
gra-1415	32	54	of	of	ADP
gra-1415	32	55	hospitals	hospital	NOUN
gra-1415	32	56	,	,	PUNCT
gra-1415	32	57	mumbai	mumbai	PROPN
gra-1415	32	58	,	,	PUNCT
gra-1415	32	59	maharashtra	maharashtra	PROPN
gra-1415	32	60	,	,	PUNCT
gra-1415	32	61	india	india	PROPN
gra-1415	32	62	*	*	PUNCT
gra-1415	32	63	corresponding	correspond	VERB
gra-1415	32	64	author	author	NOUN
gra-1415	32	65	x	x	PROPN
gra-1415	32	66	9gjra	9gjra	NUM
gra-1415	32	67	global	global	ADJ
gra-1415	32	68	journal	journal	NOUN
gra-1415	32	69	for	for	ADP
gra-1415	32	70	research	research	NOUN
gra-1415	32	71	analysis	analysis	NOUN
gra-1415	32	72	nephrology	nephrology	NOUN
gra-1415	32	73	background	background	NOUN
gra-1415	32	74	:	:	PUNCT
gra-1415	32	75	hypertension	hypertension	NOUN
gra-1415	32	76	is	be	AUX
gra-1415	32	77	more	more	ADV
gra-1415	32	78	prevalent	prevalent	ADJ
gra-1415	32	79	in	in	ADP
gra-1415	32	80	patients	patient	NOUN
gra-1415	32	81	with	with	ADP
gra-1415	32	82	chronic	chronic	ADJ
gra-1415	32	83	kidney	kidney	NOUN
gra-1415	32	84	disease	disease	NOUN
gra-1415	32	85	(	(	PUNCT
gra-1415	32	86	ckd	ckd	NOUN
gra-1415	32	87	)	)	PUNCT
gra-1415	32	88	and	and	CCONJ
gra-1415	32	89	has	have	VERB
gra-1415	32	90	a	a	DET
gra-1415	32	91	strong	strong	ADJ
gra-1415	32	92	risk	risk	NOUN
gra-1415	32	93	of	of	ADP
gra-1415	32	94	cardiovascular	cardiovascular	ADJ
gra-1415	32	95	disease	disease	NOUN
gra-1415	32	96	.	.	PUNCT
gra-1415	33	1	this	this	DET
gra-1415	33	2	study	study	NOUN
gra-1415	33	3	was	be	AUX
gra-1415	33	4	aimed	aim	VERB
gra-1415	33	5	to	to	PART
gra-1415	33	6	assess	assess	VERB
gra-1415	33	7	and	and	CCONJ
gra-1415	33	8	compare	compare	VERB
gra-1415	33	9	amlodipine	amlodipine	NOUN
gra-1415	33	10	with	with	ADP
gra-1415	33	11	cilnidipine	cilnidipine	NOUN
gra-1415	33	12	on	on	ADP
gra-1415	33	13	hemodynamic	hemodynamic	ADJ
gra-1415	33	14	parameters	parameter	NOUN
gra-1415	33	15	of	of	ADP
gra-1415	33	16	central	central	ADJ
gra-1415	33	17	blood	blood	NOUN
gra-1415	33	18	pressure	pressure	NOUN
gra-1415	33	19	and	and	CCONJ
gra-1415	33	20	arterial	arterial	ADJ
gra-1415	33	21	stiffness	stiffness	NOUN
gra-1415	33	22	in	in	ADP
gra-1415	33	23	patients	patient	NOUN
gra-1415	33	24	with	with	ADP
gra-1415	33	25	ckd	ckd	PROPN
gra-1415	33	26	on	on	ADP
gra-1415	33	27	dialysis	dialysis	NOUN
gra-1415	33	28	and	and	CCONJ
gra-1415	33	29	with	with	ADP
gra-1415	33	30	associated	associated	ADJ
gra-1415	33	31	hypertension	hypertension	NOUN
gra-1415	33	32	.	.	PUNCT
gra-1415	34	1	methods	method	NOUN
gra-1415	34	2	:	:	PUNCT
gra-1415	34	3	this	this	PRON
gra-1415	34	4	was	be	AUX
gra-1415	34	5	a	a	DET
gra-1415	34	6	prospective	prospective	ADJ
gra-1415	34	7	study	study	NOUN
gra-1415	34	8	conducted	conduct	VERB
gra-1415	34	9	between	between	ADP
gra-1415	34	10	october	october	PROPN
gra-1415	34	11	2018	2018	NUM
gra-1415	34	12	and	and	CCONJ
gra-1415	34	13	october	october	PROPN
gra-1415	34	14	2019	2019	NUM
gra-1415	34	15	.	.	PUNCT
gra-1415	35	1	patients	patient	NOUN
gra-1415	35	2	of	of	ADP
gra-1415	35	3	either	either	DET
gra-1415	35	4	sex	sex	NOUN
gra-1415	35	5	with	with	ADP
gra-1415	35	6	ckd	ckd	PROPN
gra-1415	35	7	on	on	ADP
gra-1415	35	8	dialysis	dialysis	NOUN
gra-1415	35	9	and	and	CCONJ
gra-1415	35	10	with	with	ADP
gra-1415	35	11	associated	associated	ADJ
gra-1415	35	12	hypertension	hypertension	NOUN
gra-1415	35	13	and	and	CCONJ
gra-1415	35	14	receiving	receive	VERB
gra-1415	35	15	either	either	CCONJ
gra-1415	35	16	amlodipine	amlodipine	NOUN
gra-1415	35	17	or	or	CCONJ
gra-1415	35	18	cilnidipine	cilnidipine	NOUN
gra-1415	35	19	were	be	AUX
gra-1415	35	20	included	include	VERB
gra-1415	35	21	in	in	ADP
gra-1415	35	22	the	the	DET
gra-1415	35	23	study	study	NOUN
gra-1415	35	24	.	.	PUNCT
gra-1415	36	1	mobil	mobil	PROPN
gra-1415	36	2	-	-	PUNCT
gra-1415	36	3	o	o	NOUN
gra-1415	36	4	®	®	NOUN
gra-1415	36	5	graph	graph	NOUN
gra-1415	36	6	pwa	pwa	PROPN
gra-1415	36	7	was	be	AUX
gra-1415	36	8	used	use	VERB
gra-1415	36	9	assess	assess	NOUN
gra-1415	36	10	peripheral	peripheral	ADJ
gra-1415	36	11	bp	bp	PROPN
gra-1415	36	12	,	,	PUNCT
gra-1415	36	13	vascular	vascular	ADJ
gra-1415	36	14	age	age	NOUN
gra-1415	36	15	,	,	PUNCT
gra-1415	36	16	augmentation	augmentation	NOUN
gra-1415	36	17	index	index	NOUN
gra-1415	36	18	(	(	PUNCT
gra-1415	36	19	ai	ai	NOUN
gra-1415	36	20	)	)	PUNCT
gra-1415	36	21	and	and	CCONJ
gra-1415	36	22	pulse	pulse	NOUN
gra-1415	36	23	wave	wave	NOUN
gra-1415	36	24	velocity	velocity	NOUN
gra-1415	36	25	(	(	PUNCT
gra-1415	36	26	pwv	pwv	PROPN
gra-1415	36	27	)	)	PUNCT
gra-1415	36	28	.	.	PUNCT
gra-1415	37	1	results	result	NOUN
gra-1415	37	2	:	:	PUNCT
gra-1415	37	3	a	a	DET
gra-1415	37	4	total	total	NOUN
gra-1415	37	5	of	of	ADP
gra-1415	37	6	87	87	NUM
gra-1415	37	7	patients	patient	NOUN
gra-1415	37	8	were	be	AUX
gra-1415	37	9	included	include	VERB
gra-1415	37	10	(	(	PUNCT
gra-1415	37	11	group	group	NOUN
gra-1415	37	12	1	1	NUM
gra-1415	37	13	,	,	PUNCT
gra-1415	37	14	amlodipine	amlodipine	NOUN
gra-1415	37	15	,	,	PUNCT
gra-1415	37	16	n=55	n=55	PROPN
gra-1415	37	17	;	;	PUNCT
gra-1415	37	18	group	group	NOUN
gra-1415	37	19	2	2	NUM
gra-1415	37	20	,	,	PUNCT
gra-1415	37	21	cilnidipine	cilnidipine	NOUN
gra-1415	37	22	,	,	PUNCT
gra-1415	37	23	n=22	n=22	PROPN
gra-1415	37	24	)	)	PUNCT
gra-1415	37	25	.	.	PUNCT
gra-1415	38	1	the	the	DET
gra-1415	38	2	majority	majority	NOUN
gra-1415	38	3	of	of	ADP
gra-1415	38	4	patients	patient	NOUN
gra-1415	38	5	were	be	AUX
gra-1415	38	6	men	man	NOUN
gra-1415	38	7	(	(	PUNCT
gra-1415	38	8	n=55	n=55	ADV
gra-1415	38	9	)	)	PUNCT
gra-1415	38	10	.	.	PUNCT
gra-1415	39	1	proportion	proportion	NOUN
gra-1415	39	2	of	of	ADP
gra-1415	39	3	patients	patient	NOUN
gra-1415	39	4	with	with	ADP
gra-1415	39	5	normal	normal	ADJ
gra-1415	39	6	,	,	PUNCT
gra-1415	39	7	average	average	ADJ
gra-1415	39	8	and	and	CCONJ
gra-1415	39	9	abnormal	abnormal	ADJ
gra-1415	39	10	vascular	vascular	ADJ
gra-1415	39	11	age	age	NOUN
gra-1415	39	12	and	and	CCONJ
gra-1415	39	13	arterial	arterial	ADJ
gra-1415	39	14	stiffness	stiffness	NOUN
gra-1415	39	15	was	be	AUX
gra-1415	39	16	comparable	comparable	ADJ
gra-1415	39	17	between	between	ADP
gra-1415	39	18	the	the	DET
gra-1415	39	19	treatment	treatment	NOUN
gra-1415	39	20	groups	group	NOUN
gra-1415	39	21	.	.	PUNCT
gra-1415	40	1	however	however	ADV
gra-1415	40	2	,	,	PUNCT
gra-1415	40	3	in	in	ADP
gra-1415	40	4	amlodipine	amlodipine	ADJ
gra-1415	40	5	group	group	NOUN
gra-1415	40	6	,	,	PUNCT
gra-1415	40	7	frequency	frequency	NOUN
gra-1415	40	8	of	of	ADP
gra-1415	40	9	patients	patient	NOUN
gra-1415	40	10	with	with	ADP
gra-1415	40	11	normal	normal	ADJ
gra-1415	40	12	vascular	vascular	ADJ
gra-1415	40	13	age	age	NOUN
gra-1415	40	14	(	(	PUNCT
gra-1415	40	15	42.2	42.2	NUM
gra-1415	40	16	%	%	NOUN
gra-1415	40	17	vs	vs	ADP
gra-1415	40	18	31.8	31.8	NUM
gra-1415	40	19	%	%	NOUN
gra-1415	40	20	)	)	PUNCT
gra-1415	40	21	was	be	AUX
gra-1415	40	22	comparatively	comparatively	ADV
gra-1415	40	23	higher	high	ADJ
gra-1415	40	24	and	and	CCONJ
gra-1415	40	25	frequency	frequency	NOUN
gra-1415	40	26	of	of	ADP
gra-1415	40	27	patients	patient	NOUN
gra-1415	40	28	with	with	ADP
gra-1415	40	29	average	average	ADJ
gra-1415	40	30	vascular	vascular	ADJ
gra-1415	40	31	age	age	NOUN
gra-1415	40	32	(	(	PUNCT
gra-1415	40	33	32.8	32.8	NUM
gra-1415	40	34	%	%	NOUN
gra-1415	40	35	vs	vs	ADP
gra-1415	40	36	40.9	40.9	NUM
gra-1415	40	37	%	%	NOUN
gra-1415	40	38	)	)	PUNCT
gra-1415	40	39	was	be	AUX
gra-1415	40	40	comparatively	comparatively	ADV
gra-1415	40	41	lower	low	ADJ
gra-1415	40	42	,	,	PUNCT
gra-1415	40	43	compared	compare	VERB
gra-1415	40	44	to	to	ADP
gra-1415	40	45	cilnidipine	cilnidipine	ADJ
gra-1415	40	46	group	group	NOUN
gra-1415	40	47	.	.	PUNCT
gra-1415	41	1	conclusion	conclusion	NOUN
gra-1415	41	2	:	:	PUNCT
gra-1415	41	3	both	both	PRON
gra-1415	41	4	amlodipine	amlodipine	NOUN
gra-1415	41	5	and	and	CCONJ
gra-1415	41	6	cilnidipine	cilnidipine	NOUN
gra-1415	41	7	showed	show	VERB
gra-1415	41	8	equal	equal	ADJ
gra-1415	41	9	efcacy	efcacy	NOUN
gra-1415	41	10	on	on	ADP
gra-1415	41	11	hemodynamic	hemodynamic	ADJ
gra-1415	41	12	parameters	parameter	NOUN
gra-1415	41	13	of	of	ADP
gra-1415	41	14	central	central	ADJ
gra-1415	41	15	blood	blood	NOUN
gra-1415	41	16	pressure	pressure	NOUN
gra-1415	41	17	and	and	CCONJ
gra-1415	41	18	arterial	arterial	ADJ
gra-1415	41	19	stiffness	stiffness	NOUN
gra-1415	41	20	in	in	ADP
gra-1415	41	21	studied	studied	ADJ
gra-1415	41	22	population	population	NOUN
gra-1415	41	23	.	.	PUNCT
gra-1415	42	1	abstract	abstract	ADJ
gra-1415	42	2	keywords	keyword	NOUN
gra-1415	42	3	:	:	PUNCT
gra-1415	42	4	augmentation	augmentation	NOUN
gra-1415	42	5	index	index	NOUN
gra-1415	42	6	,	,	PUNCT
gra-1415	42	7	blood	blood	NOUN
gra-1415	42	8	pressure	pressure	NOUN
gra-1415	42	9	,	,	PUNCT
gra-1415	42	10	cardiovascular	cardiovascular	ADJ
gra-1415	42	11	,	,	PUNCT
gra-1415	42	12	pulse	pulse	NOUN
gra-1415	42	13	wave	wave	NOUN
gra-1415	42	14	volume-9	volume-9	PROPN
gra-1415	42	15	,	,	PUNCT
gra-1415	42	16	issue-1	issue-1	PROPN
gra-1415	42	17	,	,	PUNCT
gra-1415	42	18	january-2020	january-2020	NOUN
gra-1415	42	19	•	•	NUM
gra-1415	42	20	print	print	NOUN
gra-1415	42	21	issn	issn	PROPN
gra-1415	42	22	no	no	NOUN
gra-1415	42	23	.	.	PROPN
gra-1415	42	24	2277	2277	NUM
gra-1415	42	25	8160	8160	NUM
gra-1415	42	26	•	•	NOUN
gra-1415	43	1	doi	doi	NOUN
gra-1415	43	2	:	:	PUNCT
gra-1415	43	3	10.36106	10.36106	NUM
gra-1415	43	4	/	/	SYM
gra-1415	43	5	gjra	gjra	PROPN
gra-1415	43	6	dr	dr	PROPN
gra-1415	43	7	.	.	PROPN
gra-1415	43	8	shahid	shahid	PROPN
gra-1415	43	9	ansari	ansari	ADJ
gra-1415	43	10	senior	senior	ADJ
gra-1415	43	11	registrar	registrar	NOUN
gra-1415	43	12	,	,	PUNCT
gra-1415	43	13	department	department	NOUN
gra-1415	43	14	of	of	ADP
gra-1415	43	15	nephrology	nephrology	NOUN
gra-1415	43	16	,	,	PUNCT
gra-1415	43	17	grant	grant	VERB
gra-1415	43	18	government	government	NOUN
gra-1415	43	19	medical	medical	PROPN
gra-1415	43	20	college	college	PROPN
gra-1415	43	21	and	and	CCONJ
gra-1415	43	22	sir	sir	PROPN
gra-1415	43	23	j.j	j.j	PROPN
gra-1415	43	24	.	.	PROPN
gra-1415	43	25	group	group	NOUN
gra-1415	43	26	of	of	ADP
gra-1415	43	27	hospitals	hospital	NOUN
gra-1415	43	28	,	,	PUNCT
gra-1415	43	29	mumbai	mumbai	PROPN
gra-1415	43	30	,	,	PUNCT
gra-1415	43	31	maharashtra	maharashtra	PROPN
gra-1415	43	32	,	,	PUNCT
gra-1415	43	33	india	india	PROPN
gra-1415	43	34	10	10	NUM
gra-1415	43	35	x	x	PROPN
gra-1415	43	36	gjra	gjra	PROPN
gra-1415	43	37	global	global	ADJ
gra-1415	43	38	journal	journal	PROPN
gra-1415	43	39	for	for	ADP
gra-1415	43	40	research	research	NOUN
gra-1415	43	41	analysis	analysis	NOUN
gra-1415	43	42	the	the	DET
gra-1415	43	43	patients	patient	NOUN
gra-1415	43	44	were	be	AUX
gra-1415	43	45	divided	divide	VERB
gra-1415	43	46	into	into	ADP
gra-1415	43	47	group	group	NOUN
gra-1415	43	48	1	1	NUM
gra-1415	43	49	,	,	PUNCT
gra-1415	43	50	patients	patient	NOUN
gra-1415	43	51	treated	treat	VERB
gra-1415	43	52	with	with	ADP
gra-1415	43	53	amlodipine	amlodipine	NOUN
gra-1415	43	54	(	(	PUNCT
gra-1415	43	55	n=65	n=65	NOUN
gra-1415	43	56	)	)	PUNCT
gra-1415	43	57	and	and	CCONJ
gra-1415	43	58	group	group	NOUN
gra-1415	43	59	2	2	NUM
gra-1415	43	60	,	,	PUNCT
gra-1415	43	61	patients	patient	NOUN
gra-1415	43	62	treated	treat	VERB
gra-1415	43	63	with	with	ADP
gra-1415	43	64	cilnidipine	cilnidipine	NOUN
gra-1415	43	65	(	(	PUNCT
gra-1415	43	66	n=22	n=22	PROPN
gra-1415	43	67	)	)	PUNCT
gra-1415	43	68	.	.	PUNCT
gra-1415	44	1	table	table	NOUN
gra-1415	44	2	1	1	NUM
gra-1415	44	3	:	:	PUNCT
gra-1415	44	4	demographic	demographic	ADJ
gra-1415	44	5	and	and	CCONJ
gra-1415	44	6	clinical	clinical	ADJ
gra-1415	44	7	characteristics	characteristic	NOUN
gra-1415	44	8	of	of	ADP
gra-1415	44	9	participants	participant	NOUN
gra-1415	44	10	the	the	DET
gra-1415	44	11	mean	mean	ADJ
gra-1415	44	12	age	age	NOUN
gra-1415	44	13	of	of	ADP
gra-1415	44	14	patients	patient	NOUN
gra-1415	44	15	from	from	ADP
gra-1415	44	16	group	group	NOUN
gra-1415	44	17	1	1	NUM
gra-1415	44	18	was	be	AUX
gra-1415	44	19	53.66	53.66	NUM
gra-1415	44	20	years	year	NOUN
gra-1415	44	21	while	while	SCONJ
gra-1415	44	22	the	the	DET
gra-1415	44	23	mean	mean	ADJ
gra-1415	44	24	age	age	NOUN
gra-1415	44	25	of	of	ADP
gra-1415	44	26	patients	patient	NOUN
gra-1415	44	27	from	from	ADP
gra-1415	44	28	group	group	NOUN
gra-1415	44	29	2	2	NUM
gra-1415	44	30	was	be	AUX
gra-1415	44	31	50.36	50.36	NUM
gra-1415	44	32	years	year	NOUN
gra-1415	44	33	with	with	ADP
gra-1415	44	34	male	male	ADJ
gra-1415	44	35	predominance	predominance	NOUN
gra-1415	44	36	in	in	ADP
gra-1415	44	37	both	both	CCONJ
gra-1415	44	38	the	the	DET
gra-1415	44	39	groups	group	NOUN
gra-1415	44	40	(	(	PUNCT
gra-1415	44	41	60	60	NUM
gra-1415	44	42	%	%	NOUN
gra-1415	44	43	vs	vs	ADP
gra-1415	44	44	72.7	72.7	NUM
gra-1415	44	45	%	%	NOUN
gra-1415	44	46	)	)	PUNCT
gra-1415	44	47	.	.	PUNCT
gra-1415	45	1	antihypertensive	antihypertensive	ADJ
gra-1415	45	2	efcacy	efcacy	NOUN
gra-1415	45	3	of	of	ADP
gra-1415	45	4	amlodipine	amlodipine	NOUN
gra-1415	45	5	and	and	CCONJ
gra-1415	45	6	cilnidipine	cilnidipine	ADJ
gra-1415	45	7	drug	drug	NOUN
gra-1415	45	8	therapy	therapy	NOUN
gra-1415	45	9	was	be	AUX
gra-1415	45	10	found	find	VERB
gra-1415	45	11	to	to	PART
gra-1415	45	12	be	be	AUX
gra-1415	45	13	comparable	comparable	ADJ
gra-1415	45	14	(	(	PUNCT
gra-1415	45	15	figure	figure	NOUN
gra-1415	45	16	1	1	NUM
gra-1415	45	17	)	)	PUNCT
gra-1415	45	18	.	.	PUNCT
gra-1415	46	1	sbp	sbp	PROPN
gra-1415	46	2	,	,	PUNCT
gra-1415	46	3	systolic	systolic	ADJ
gra-1415	46	4	blood	blood	NOUN
gra-1415	46	5	pressure	pressure	NOUN
gra-1415	46	6	;	;	PUNCT
gra-1415	46	7	dbp	dbp	PROPN
gra-1415	46	8	,	,	PUNCT
gra-1415	46	9	diastolic	diastolic	ADJ
gra-1415	46	10	blood	blood	NOUN
gra-1415	46	11	pressure	pressure	NOUN
gra-1415	46	12	.	.	PUNCT
gra-1415	47	1	figure	figure	NOUN
gra-1415	47	2	1	1	NUM
gra-1415	47	3	.	.	PUNCT
gra-1415	47	4	antihypertensive	antihypertensive	ADJ
gra-1415	47	5	efcacy	efcacy	NOUN
gra-1415	47	6	of	of	ADP
gra-1415	47	7	amlodipine	amlodipine	NOUN
gra-1415	47	8	and	and	CCONJ
gra-1415	47	9	cilnidipine	cilnidipine	ADJ
gra-1415	47	10	treatment	treatment	NOUN
gra-1415	47	11	proportion	proportion	NOUN
gra-1415	47	12	of	of	ADP
gra-1415	47	13	patients	patient	NOUN
gra-1415	47	14	with	with	ADP
gra-1415	47	15	normal	normal	ADJ
gra-1415	47	16	,	,	PUNCT
gra-1415	47	17	average	average	ADJ
gra-1415	47	18	and	and	CCONJ
gra-1415	47	19	abnormal	abnormal	ADJ
gra-1415	47	20	vascular	vascular	NOUN
gra-1415	47	21	age	age	NOUN
gra-1415	47	22	was	be	AUX
gra-1415	47	23	comparable	comparable	ADJ
gra-1415	47	24	between	between	ADP
gra-1415	47	25	the	the	DET
gra-1415	47	26	treatment	treatment	NOUN
gra-1415	47	27	groups	group	NOUN
gra-1415	47	28	(	(	PUNCT
gra-1415	47	29	p=0.675	p=0.675	NOUN
gra-1415	47	30	)	)	PUNCT
gra-1415	47	31	.	.	PUNCT
gra-1415	48	1	however	however	ADV
gra-1415	48	2	,	,	PUNCT
gra-1415	48	3	in	in	ADP
gra-1415	48	4	amlodipine	amlodipine	ADJ
gra-1415	48	5	group	group	NOUN
gra-1415	48	6	,	,	PUNCT
gra-1415	48	7	frequency	frequency	NOUN
gra-1415	48	8	of	of	ADP
gra-1415	48	9	patients	patient	NOUN
gra-1415	48	10	with	with	ADP
gra-1415	48	11	normal	normal	ADJ
gra-1415	48	12	vascular	vascular	ADJ
gra-1415	48	13	age	age	NOUN
gra-1415	48	14	(	(	PUNCT
gra-1415	48	15	42.2	42.2	NUM
gra-1415	48	16	%	%	NOUN
gra-1415	48	17	vs	vs	ADP
gra-1415	48	18	31.8	31.8	NUM
gra-1415	48	19	%	%	NOUN
gra-1415	48	20	)	)	PUNCT
gra-1415	48	21	was	be	AUX
gra-1415	48	22	comparatively	comparatively	ADV
gra-1415	48	23	higher	high	ADJ
gra-1415	48	24	and	and	CCONJ
gra-1415	48	25	frequency	frequency	NOUN
gra-1415	48	26	of	of	ADP
gra-1415	48	27	patients	patient	NOUN
gra-1415	48	28	with	with	ADP
gra-1415	48	29	average	average	ADJ
gra-1415	48	30	vascular	vascular	ADJ
gra-1415	48	31	age	age	NOUN
gra-1415	48	32	(	(	PUNCT
gra-1415	48	33	32.8	32.8	NUM
gra-1415	48	34	%	%	NOUN
gra-1415	48	35	vs	vs	ADP
gra-1415	48	36	40.9	40.9	NUM
gra-1415	48	37	%	%	NOUN
gra-1415	48	38	)	)	PUNCT
gra-1415	48	39	was	be	AUX
gra-1415	48	40	comparatively	comparatively	ADV
gra-1415	48	41	lower	low	ADJ
gra-1415	48	42	,	,	PUNCT
gra-1415	48	43	compared	compare	VERB
gra-1415	48	44	to	to	ADP
gra-1415	48	45	cilnidipine	cilnidipine	ADJ
gra-1415	48	46	group	group	NOUN
gra-1415	48	47	.	.	PUNCT
gra-1415	49	1	frequency	frequency	NOUN
gra-1415	49	2	of	of	ADP
gra-1415	49	3	patients	patient	NOUN
gra-1415	49	4	from	from	ADP
gra-1415	49	5	both	both	CCONJ
gra-1415	49	6	the	the	DET
gra-1415	49	7	treatment	treatment	NOUN
gra-1415	49	8	groups	group	NOUN
gra-1415	49	9	was	be	AUX
gra-1415	49	10	similar	similar	ADJ
gra-1415	49	11	when	when	SCONJ
gra-1415	49	12	categorized	categorize	VERB
gra-1415	49	13	according	accord	VERB
gra-1415	49	14	to	to	ADP
gra-1415	49	15	small	small	ADJ
gra-1415	49	16	and	and	CCONJ
gra-1415	49	17	large	large	ADJ
gra-1415	49	18	arterial	arterial	ADJ
gra-1415	49	19	stiffness	stiffness	NOUN
gra-1415	49	20	(	(	PUNCT
gra-1415	49	21	p	p	NOUN
gra-1415	49	22	=	=	NOUN
gra-1415	49	23	0.945	0.945	NUM
gra-1415	49	24	and	and	CCONJ
gra-1415	49	25	0.850	0.850	NUM
gra-1415	49	26	,	,	PUNCT
gra-1415	49	27	respectively	respectively	ADV
gra-1415	49	28	)	)	PUNCT
gra-1415	49	29	.	.	PUNCT
gra-1415	50	1	majority	majority	NOUN
gra-1415	50	2	of	of	ADP
gra-1415	50	3	patients	patient	NOUN
gra-1415	50	4	had	have	VERB
gra-1415	50	5	normal	normal	ADJ
gra-1415	50	6	small	small	ADJ
gra-1415	50	7	arterial	arterial	ADJ
gra-1415	50	8	stiffness	stiffness	NOUN
gra-1415	50	9	in	in	ADP
gra-1415	50	10	both	both	CCONJ
gra-1415	50	11	the	the	DET
gra-1415	50	12	groups	group	NOUN
gra-1415	50	13	while	while	SCONJ
gra-1415	50	14	average	average	ADJ
gra-1415	50	15	and	and	CCONJ
gra-1415	50	16	abnormal	abnormal	ADJ
gra-1415	50	17	levels	level	NOUN
gra-1415	50	18	of	of	ADP
gra-1415	50	19	large	large	ADJ
gra-1415	50	20	arterial	arterial	ADJ
gra-1415	50	21	stiffness	stiffness	NOUN
gra-1415	50	22	were	be	AUX
gra-1415	50	23	commonly	commonly	ADV
gra-1415	50	24	observed	observe	VERB
gra-1415	50	25	in	in	ADP
gra-1415	50	26	both	both	CCONJ
gra-1415	50	27	the	the	DET
gra-1415	50	28	groups	group	NOUN
gra-1415	50	29	.	.	PUNCT
gra-1415	51	1	mean	mean	ADJ
gra-1415	51	2	peripheral	peripheral	ADJ
gra-1415	51	3	bp	bp	PROPN
gra-1415	51	4	was	be	AUX
gra-1415	51	5	comparable	comparable	ADJ
gra-1415	51	6	between	between	ADP
gra-1415	51	7	both	both	CCONJ
gra-1415	51	8	the	the	DET
gra-1415	51	9	groups	group	NOUN
gra-1415	51	10	.	.	PUNCT
gra-1415	52	1	the	the	DET
gra-1415	52	2	average	average	ADJ
gra-1415	52	3	pulse	pulse	NOUN
gra-1415	52	4	pressure	pressure	NOUN
gra-1415	52	5	was	be	AUX
gra-1415	52	6	slightly	slightly	ADV
gra-1415	52	7	higher	high	ADJ
gra-1415	52	8	in	in	ADP
gra-1415	52	9	patients	patient	NOUN
gra-1415	52	10	from	from	ADP
gra-1415	52	11	cilnidipine	cilnidipine	ADJ
gra-1415	52	12	group	group	NOUN
gra-1415	52	13	than	than	ADP
gra-1415	52	14	those	those	PRON
gra-1415	52	15	from	from	ADP
gra-1415	52	16	amlodipine	amlodipine	NOUN
gra-1415	52	17	group	group	NOUN
gra-1415	52	18	without	without	ADP
gra-1415	52	19	any	any	DET
gra-1415	52	20	signicant	signicant	ADJ
gra-1415	52	21	difference	difference	NOUN
gra-1415	52	22	(	(	PUNCT
gra-1415	52	23	p=0.093	p=0.093	NUM
gra-1415	52	24	)	)	PUNCT
gra-1415	52	25	.	.	PUNCT
gra-1415	53	1	augmentation	augmentation	NOUN
gra-1415	53	2	index	index	NOUN
gra-1415	53	3	was	be	AUX
gra-1415	53	4	comparatively	comparatively	ADV
gra-1415	53	5	higher	high	ADJ
gra-1415	53	6	in	in	ADP
gra-1415	53	7	patients	patient	NOUN
gra-1415	53	8	taking	take	VERB
gra-1415	53	9	cilnidipine	cilnidipine	NOUN
gra-1415	53	10	(	(	PUNCT
gra-1415	53	11	p=0.411	p=0.411	NOUN
gra-1415	53	12	)	)	PUNCT
gra-1415	53	13	compared	compare	VERB
gra-1415	53	14	to	to	ADP
gra-1415	53	15	those	those	PRON
gra-1415	53	16	taking	take	VERB
gra-1415	53	17	amlodipine	amlodipine	NOUN
gra-1415	53	18	(	(	PUNCT
gra-1415	53	19	p=0.411	p=0.411	NOUN
gra-1415	53	20	)	)	PUNCT
gra-1415	53	21	.	.	PUNCT
gra-1415	54	1	pulse	pulse	NOUN
gra-1415	54	2	wave	wave	NOUN
gra-1415	54	3	velocity	velocity	NOUN
gra-1415	54	4	was	be	AUX
gra-1415	54	5	similar	similar	ADJ
gra-1415	54	6	between	between	ADP
gra-1415	54	7	both	both	CCONJ
gra-1415	54	8	the	the	DET
gra-1415	54	9	group	group	NOUN
gra-1415	54	10	(	(	PUNCT
gra-1415	54	11	p=0.565	p=0.565	ADV
gra-1415	54	12	)	)	PUNCT
gra-1415	54	13	(	(	PUNCT
gra-1415	54	14	table	table	NOUN
gra-1415	54	15	2	2	NUM
gra-1415	54	16	)	)	PUNCT
gra-1415	54	17	.	.	PUNCT
gra-1415	55	1	discussion	discussion	NOUN
gra-1415	55	2	this	this	DET
gra-1415	55	3	study	study	NOUN
gra-1415	55	4	assessed	assess	VERB
gra-1415	55	5	and	and	CCONJ
gra-1415	55	6	compared	compare	VERB
gra-1415	55	7	vital	vital	ADJ
gra-1415	55	8	hemodynamic	hemodynamic	ADJ
gra-1415	55	9	parameters	parameter	NOUN
gra-1415	55	10	of	of	ADP
gra-1415	55	11	central	central	ADJ
gra-1415	55	12	blood	blood	NOUN
gra-1415	55	13	pressure	pressure	NOUN
gra-1415	55	14	and	and	CCONJ
gra-1415	55	15	arterial	arterial	ADJ
gra-1415	55	16	stiffness	stiffness	NOUN
gra-1415	55	17	measured	measure	VERB
gra-1415	55	18	by	by	ADP
gra-1415	55	19	oscillometric	oscillometric	ADJ
gra-1415	55	20	methods	method	NOUN
gra-1415	55	21	in	in	ADP
gra-1415	55	22	patients	patient	NOUN
gra-1415	55	23	with	with	ADP
gra-1415	55	24	ckd	ckd	PROPN
gra-1415	55	25	on	on	ADP
gra-1415	55	26	dialysis	dialysis	NOUN
gra-1415	55	27	and	and	CCONJ
gra-1415	55	28	with	with	ADP
gra-1415	55	29	associated	associated	ADJ
gra-1415	55	30	hypertension	hypertension	NOUN
gra-1415	55	31	treated	treat	VERB
gra-1415	55	32	with	with	ADP
gra-1415	55	33	two	two	NUM
gra-1415	55	34	types	type	NOUN
gra-1415	55	35	of	of	ADP
gra-1415	55	36	calcium	calcium	NOUN
gra-1415	55	37	channel	channel	NOUN
gra-1415	55	38	blockers	blocker	NOUN
gra-1415	55	39	;	;	PUNCT
gra-1415	55	40	amlodipine	amlodipine	NOUN
gra-1415	55	41	,	,	PUNCT
gra-1415	55	42	a	a	DET
gra-1415	55	43	l	l	NOUN
gra-1415	55	44	-	-	PUNCT
gra-1415	55	45	type	type	NOUN
gra-1415	55	46	ca	can	AUX
gra-1415	55	47	channel	channel	NOUN
gra-1415	55	48	blocker	blocker	NOUN
gra-1415	55	49	and	and	CCONJ
gra-1415	55	50	cilnidipine	cilnidipine	NOUN
gra-1415	55	51	,	,	PUNCT
gra-1415	55	52	n	n	CCONJ
gra-1415	55	53	/	/	SYM
gra-1415	55	54	l	l	NOUN
gra-1415	55	55	-	-	NOUN
gra-1415	55	56	type	type	NOUN
gra-1415	55	57	ca	can	AUX
gra-1415	55	58	channel	channel	NOUN
gra-1415	55	59	blocker	blocker	NOUN
gra-1415	55	60	.	.	PUNCT
gra-1415	56	1	overall	overall	ADJ
gra-1415	56	2	observations	observation	NOUN
gra-1415	56	3	demonstrated	demonstrate	VERB
gra-1415	56	4	no	no	DET
gra-1415	56	5	signicant	signicant	ADJ
gra-1415	56	6	difference	difference	NOUN
gra-1415	56	7	in	in	ADP
gra-1415	56	8	any	any	PRON
gra-1415	56	9	of	of	ADP
gra-1415	56	10	the	the	DET
gra-1415	56	11	pulse	pulse	NOUN
gra-1415	56	12	wave	wave	NOUN
gra-1415	56	13	analysis	analysis	NOUN
gra-1415	56	14	parameters	parameter	NOUN
gra-1415	56	15	between	between	ADP
gra-1415	56	16	the	the	DET
gra-1415	56	17	two	two	NUM
gra-1415	56	18	treatment	treatment	NOUN
gra-1415	56	19	groups	group	NOUN
gra-1415	56	20	indicating	indicate	VERB
gra-1415	56	21	similar	similar	ADJ
gra-1415	56	22	effect	effect	NOUN
gra-1415	56	23	of	of	ADP
gra-1415	56	24	l	l	NOUN
gra-1415	56	25	-	-	NOUN
gra-1415	56	26	type	type	NOUN
gra-1415	56	27	and	and	CCONJ
gra-1415	56	28	n	n	CCONJ
gra-1415	56	29	/	/	SYM
gra-1415	56	30	ltype	ltype	NOUN
gra-1415	56	31	calcium	calcium	NOUN
gra-1415	56	32	channel	channel	NOUN
gra-1415	56	33	blockers	blocker	NOUN
gra-1415	56	34	on	on	ADP
gra-1415	56	35	these	these	DET
gra-1415	56	36	patients	patient	NOUN
gra-1415	56	37	.	.	PUNCT
gra-1415	57	1	to	to	ADP
gra-1415	57	2	our	our	PRON
gra-1415	57	3	knowledge	knowledge	NOUN
gra-1415	57	4	,	,	PUNCT
gra-1415	57	5	there	there	PRON
gra-1415	57	6	is	be	VERB
gra-1415	57	7	no	no	DET
gra-1415	57	8	similar	similar	ADJ
gra-1415	57	9	study	study	NOUN
gra-1415	57	10	conducted	conduct	VERB
gra-1415	57	11	to	to	PART
gra-1415	57	12	compare	compare	VERB
gra-1415	57	13	these	these	DET
gra-1415	57	14	observations	observation	NOUN
gra-1415	57	15	with	with	ADP
gra-1415	57	16	amlodipine	amlodipine	NOUN
gra-1415	57	17	and	and	CCONJ
gra-1415	57	18	cilnidipine	cilnidipine	NOUN
gra-1415	57	19	.	.	PUNCT
gra-1415	58	1	however	however	ADV
gra-1415	58	2	,	,	PUNCT
gra-1415	58	3	several	several	ADJ
gra-1415	58	4	past	past	ADJ
gra-1415	58	5	studies	study	NOUN
gra-1415	58	6	have	have	AUX
gra-1415	58	7	compared	compare	VERB
gra-1415	58	8	amlodipine	amlodipine	NOUN
gra-1415	58	9	with	with	ADP
gra-1415	58	10	cilnidipine	cilnidipine	NOUN
gra-1415	58	11	on	on	ADP
gra-1415	58	12	antihypertensive	antihypertensive	ADJ
gra-1415	58	13	efcacy	efcacy	NOUN
gra-1415	58	14	and	and	CCONJ
gra-1415	58	15	incidence	incidence	NOUN
gra-1415	58	16	of	of	ADP
gra-1415	58	17	pedal	pedal	ADJ
gra-1415	58	18	edema	edema	NOUN
gra-1415	58	19	in	in	ADP
gra-1415	58	20	hypertensive	hypertensive	ADJ
gra-1415	58	21	individuals	individual	NOUN
gra-1415	58	22	.	.	PUNCT
gra-1415	59	1	two	two	NUM
gra-1415	59	2	studies	study	NOUN
gra-1415	59	3	from	from	ADP
gra-1415	59	4	southern	southern	ADJ
gra-1415	59	5	part	part	NOUN
gra-1415	59	6	of	of	ADP
gra-1415	59	7	india	india	PROPN
gra-1415	59	8	demonstrated	demonstrate	VERB
gra-1415	59	9	equal	equal	ADJ
gra-1415	59	10	efcacy	efcacy	NOUN
gra-1415	59	11	of	of	ADP
gra-1415	59	12	cilnidipine	cilnidipine	NOUN
gra-1415	59	13	and	and	CCONJ
gra-1415	59	14	amlodipine	amlodipine	NOUN
gra-1415	59	15	in	in	ADP
gra-1415	59	16	reducing	reduce	VERB
gra-1415	59	17	blood	blood	NOUN
gra-1415	59	18	pressure	pressure	NOUN
gra-1415	59	19	in	in	ADP
gra-1415	59	20	hypertensive	hypertensive	ADJ
gra-1415	59	21	individuals	individual	NOUN
gra-1415	59	22	[	[	X
gra-1415	59	23	6	6	NUM
gra-1415	59	24	,	,	PUNCT
gra-1415	59	25	7	7	NUM
gra-1415	59	26	]	]	PUNCT
gra-1415	59	27	.	.	PUNCT
gra-1415	60	1	however	however	ADV
gra-1415	60	2	,	,	PUNCT
gra-1415	60	3	cilnidipine	cilnidipine	ADJ
gra-1415	60	4	being	be	AUX
gra-1415	60	5	n	n	CCONJ
gra-1415	60	6	-	-	PUNCT
gra-1415	60	7	type	type	NOUN
gra-1415	60	8	and	and	CCONJ
gra-1415	60	9	l	l	NOUN
gra-1415	60	10	-	-	PUNCT
gra-1415	60	11	type	type	NOUN
gra-1415	60	12	calcium	calcium	NOUN
gra-1415	60	13	channel	channel	NOUN
gra-1415	60	14	blocker	blocker	NOUN
gra-1415	60	15	,	,	PUNCT
gra-1415	60	16	associated	associate	VERB
gra-1415	60	17	with	with	ADP
gra-1415	60	18	lower	low	ADJ
gra-1415	60	19	incidence	incidence	NOUN
gra-1415	60	20	of	of	ADP
gra-1415	60	21	pedal	pedal	ADJ
gra-1415	60	22	edema	edema	NOUN
gra-1415	60	23	compared	compare	VERB
gra-1415	60	24	to	to	ADP
gra-1415	60	25	only	only	ADV
gra-1415	60	26	l	l	ADJ
gra-1415	60	27	-	-	PUNCT
gra-1415	60	28	type	type	NOUN
gra-1415	60	29	channel	channel	NOUN
gra-1415	60	30	blocked	block	VERB
gra-1415	60	31	by	by	ADP
gra-1415	60	32	amlodipine	amlodipine	NOUN
gra-1415	60	33	.	.	PUNCT
gra-1415	60	34	table	table	NOUN
gra-1415	61	1	2	2	NUM
gra-1415	61	2	:	:	PUNCT
gra-1415	61	3	comparison	comparison	NOUN
gra-1415	61	4	of	of	ADP
gra-1415	61	5	parameters	parameter	NOUN
gra-1415	61	6	between	between	ADP
gra-1415	61	7	the	the	DET
gra-1415	61	8	treatment	treatment	NOUN
gra-1415	61	9	groups	group	NOUN
gra-1415	61	10	there	there	PRON
gra-1415	61	11	are	be	VERB
gra-1415	61	12	few	few	ADJ
gra-1415	61	13	studies	study	NOUN
gra-1415	61	14	which	which	PRON
gra-1415	61	15	reported	report	VERB
gra-1415	61	16	cilnidipine	cilnidipine	NOUN
gra-1415	61	17	is	be	AUX
gra-1415	61	18	more	more	ADV
gra-1415	61	19	effective	effective	ADJ
gra-1415	61	20	than	than	ADP
gra-1415	61	21	amlodipine	amlodipine	NOUN
gra-1415	61	22	at	at	ADP
gra-1415	61	23	improving	improve	VERB
gra-1415	61	24	renal	renal	ADJ
gra-1415	61	25	function	function	NOUN
gra-1415	61	26	and	and	CCONJ
gra-1415	61	27	arterial	arterial	ADJ
gra-1415	61	28	stiffness	stiffness	NOUN
gra-1415	61	29	[	[	X
gra-1415	61	30	8	8	NUM
gra-1415	61	31	]	]	PUNCT
gra-1415	61	32	and	and	CCONJ
gra-1415	61	33	albuminuria	albuminuria	PROPN
gra-1415	61	34	and	and	CCONJ
gra-1415	61	35	uric	uric	ADJ
gra-1415	61	36	acid	acid	NOUN
gra-1415	61	37	metabolism	metabolism	NOUN
gra-1415	61	38	[	[	X
gra-1415	61	39	12	12	NUM
gra-1415	61	40	]	]	PUNCT
gra-1415	61	41	in	in	ADP
gra-1415	61	42	patients	patient	NOUN
gra-1415	61	43	with	with	ADP
gra-1415	61	44	essential	essential	ADJ
gra-1415	61	45	hypertension	hypertension	NOUN
gra-1415	61	46	and	and	CCONJ
gra-1415	61	47	in	in	ADP
gra-1415	61	48	hypertensive	hypertensive	ADJ
gra-1415	61	49	patients	patient	NOUN
gra-1415	61	50	with	with	ADP
gra-1415	61	51	ckd	ckd	PROPN
gra-1415	61	52	,	,	PUNCT
gra-1415	61	53	respectively	respectively	ADV
gra-1415	61	54	.	.	PUNCT
gra-1415	62	1	volume-9	volume-9	NUM
gra-1415	62	2	,	,	PUNCT
gra-1415	62	3	issue-1	issue-1	PROPN
gra-1415	62	4	,	,	PUNCT
gra-1415	62	5	january-2020	january-2020	NOUN
gra-1415	62	6	•	•	NUM
gra-1415	62	7	print	print	NOUN
gra-1415	62	8	issn	issn	PROPN
gra-1415	62	9	no	no	NOUN
gra-1415	62	10	.	.	PROPN
gra-1415	62	11	2277	2277	NUM
gra-1415	62	12	8160	8160	NUM
gra-1415	62	13	•	•	NOUN
gra-1415	62	14	doi	doi	NOUN
gra-1415	62	15	:	:	PUNCT
gra-1415	62	16	10.36106	10.36106	NUM
gra-1415	62	17	/	/	SYM
gra-1415	62	18	gjra	gjra	NOUN
gra-1415	62	19	characteristics	characteristic	NOUN
gra-1415	62	20	total	total	NOUN
gra-1415	62	21	(	(	PUNCT
gra-1415	62	22	n=	n=	ADJ
gra-1415	62	23	87	87	NUM
gra-1415	62	24	)	)	PUNCT
gra-1415	62	25	age	age	NOUN
gra-1415	62	26	(	(	PUNCT
gra-1415	62	27	years	year	NOUN
gra-1415	62	28	)	)	PUNCT
gra-1415	62	29	52.83	52.83	NUM
gra-1415	62	30	(	(	PUNCT
gra-1415	62	31	12.64	12.64	NUM
gra-1415	62	32	)	)	PUNCT
gra-1415	62	33	sex	sex	NOUN
gra-1415	62	34	male	male	NOUN
gra-1415	62	35	,	,	PUNCT
gra-1415	62	36	n	n	CCONJ
gra-1415	62	37	(	(	PUNCT
gra-1415	62	38	%	%	INTJ
gra-1415	62	39	)	)	PUNCT
gra-1415	62	40	55	55	NUM
gra-1415	62	41	(	(	PUNCT
gra-1415	62	42	63.20	63.20	NUM
gra-1415	62	43	)	)	PUNCT
gra-1415	62	44	female	female	NOUN
gra-1415	62	45	,	,	PUNCT
gra-1415	62	46	n	n	CCONJ
gra-1415	62	47	(	(	PUNCT
gra-1415	62	48	%	%	INTJ
gra-1415	62	49	)	)	PUNCT
gra-1415	62	50	32	32	NUM
gra-1415	62	51	(	(	PUNCT
gra-1415	62	52	36.80	36.80	NUM
gra-1415	62	53	)	)	PUNCT
gra-1415	62	54	bmi	bmi	NOUN
gra-1415	62	55	(	(	PUNCT
gra-1415	62	56	kg	kg	NOUN
gra-1415	62	57	/	/	SYM
gra-1415	62	58	m2	m2	PROPN
gra-1415	62	59	)	)	PUNCT
gra-1415	62	60	22.72	22.72	NUM
gra-1415	62	61	(	(	PUNCT
gra-1415	62	62	3.33	3.33	NUM
gra-1415	62	63	)	)	PUNCT
gra-1415	62	64	peripheral	peripheral	ADJ
gra-1415	62	65	bp	bp	PROPN
gra-1415	62	66	(	(	PUNCT
gra-1415	62	67	mmhg	mmhg	PROPN
gra-1415	62	68	)	)	PUNCT
gra-1415	62	69	systole	systole	NOUN
gra-1415	62	70	128	128	NUM
gra-1415	62	71	(	(	PUNCT
gra-1415	62	72	86	86	NUM
gra-1415	62	73	-	-	PUNCT
gra-1415	62	74	201	201	NUM
gra-1415	62	75	)	)	PUNCT
gra-1415	62	76	diastole	diastole	NOUN
gra-1415	62	77	86	86	NUM
gra-1415	62	78	(	(	PUNCT
gra-1415	62	79	58	58	NUM
gra-1415	62	80	-	-	SYM
gra-1415	62	81	130	130	NUM
gra-1415	62	82	)	)	PUNCT
gra-1415	62	83	pulse	pulse	NOUN
gra-1415	62	84	pressure	pressure	NOUN
gra-1415	62	85	(	(	PUNCT
gra-1415	62	86	mmhg	mmhg	PROPN
gra-1415	62	87	)	)	PUNCT
gra-1415	62	88	40	40	NUM
gra-1415	62	89	(	(	PUNCT
gra-1415	62	90	19	19	NUM
gra-1415	62	91	-	-	SYM
gra-1415	62	92	79	79	NUM
gra-1415	62	93	)	)	PUNCT
gra-1415	62	94	heart	heart	NOUN
gra-1415	62	95	rate	rate	NOUN
gra-1415	62	96	(	(	PUNCT
gra-1415	62	97	bpm	bpm	NOUN
gra-1415	62	98	)	)	PUNCT
gra-1415	62	99	85.49	85.49	NUM
gra-1415	62	100	(	(	PUNCT
gra-1415	62	101	17.30	17.30	NUM
gra-1415	62	102	)	)	PUNCT
gra-1415	62	103	arterial	arterial	ADJ
gra-1415	62	104	bp	bp	PROPN
gra-1415	62	105	(	(	PUNCT
gra-1415	62	106	mmhg	mmhg	PROPN
gra-1415	62	107	)	)	PUNCT
gra-1415	62	108	105	105	NUM
gra-1415	62	109	(	(	PUNCT
gra-1415	62	110	76	76	NUM
gra-1415	62	111	-	-	SYM
gra-1415	62	112	159	159	NUM
gra-1415	62	113	)	)	PUNCT
gra-1415	62	114	augmentation	augmentation	NOUN
gra-1415	62	115	index	index	NOUN
gra-1415	62	116	(	(	PUNCT
gra-1415	62	117	%	%	INTJ
gra-1415	62	118	)	)	PUNCT
gra-1415	62	119	25.83	25.83	NUM
gra-1415	62	120	(	(	PUNCT
gra-1415	62	121	11.25	11.25	NUM
gra-1415	62	122	)	)	PUNCT
gra-1415	62	123	pulse	pulse	NOUN
gra-1415	62	124	wave	wave	NOUN
gra-1415	62	125	velocity	velocity	NOUN
gra-1415	62	126	(	(	PUNCT
gra-1415	62	127	m	m	NOUN
gra-1415	62	128	/	/	SYM
gra-1415	62	129	s	s	PROPN
gra-1415	62	130	)	)	PUNCT
gra-1415	62	131	7.84	7.84	NUM
gra-1415	62	132	(	(	PUNCT
gra-1415	62	133	1.65	1.65	NUM
gra-1415	62	134	)	)	PUNCT
gra-1415	62	135	vascular	vascular	ADJ
gra-1415	62	136	age	age	NOUN
gra-1415	62	137	normal	normal	ADJ
gra-1415	62	138	34	34	NUM
gra-1415	62	139	(	(	PUNCT
gra-1415	62	140	39.5	39.5	NUM
gra-1415	62	141	)	)	PUNCT
gra-1415	62	142	average	average	ADJ
gra-1415	62	143	30	30	NUM
gra-1415	62	144	(	(	PUNCT
gra-1415	62	145	34.9	34.9	NUM
gra-1415	62	146	)	)	PUNCT
gra-1415	62	147	abnormal	abnormal	ADJ
gra-1415	62	148	22	22	NUM
gra-1415	62	149	(	(	PUNCT
gra-1415	62	150	25.6	25.6	NUM
gra-1415	62	151	)	)	PUNCT
gra-1415	62	152	central	central	ADJ
gra-1415	62	153	bp	bp	PROPN
gra-1415	62	154	(	(	PUNCT
gra-1415	62	155	mmhg	mmhg	PROPN
gra-1415	62	156	)	)	PUNCT
gra-1415	62	157	systole	systole	VERB
gra-1415	62	158	119.08	119.08	NUM
gra-1415	62	159	(	(	PUNCT
gra-1415	62	160	16.89	16.89	NUM
gra-1415	62	161	)	)	PUNCT
gra-1415	62	162	diastole	diastole	NOUN
gra-1415	62	163	88	88	NUM
gra-1415	62	164	(	(	PUNCT
gra-1415	62	165	59	59	NUM
gra-1415	62	166	-	-	SYM
gra-1415	62	167	132	132	NUM
gra-1415	62	168	)	)	PUNCT
gra-1415	62	169	arterial	arterial	ADJ
gra-1415	62	170	stiffness	stiffness	ADJ
gra-1415	62	171	small	small	ADJ
gra-1415	62	172	arteries	artery	NOUN
gra-1415	62	173	26.19	26.19	NUM
gra-1415	62	174	(	(	PUNCT
gra-1415	62	175	10.36	10.36	NUM
gra-1415	62	176	)	)	PUNCT
gra-1415	62	177	large	large	ADJ
gra-1415	62	178	arteries	artery	NOUN
gra-1415	62	179	7.84	7.84	NUM
gra-1415	62	180	(	(	PUNCT
gra-1415	62	181	1.65	1.65	NUM
gra-1415	62	182	)	)	PUNCT
gra-1415	62	183	data	datum	NOUN
gra-1415	62	184	shown	show	VERB
gra-1415	62	185	as	as	ADP
gra-1415	62	186	media	medium	NOUN
gra-1415	62	187	(	(	PUNCT
gra-1415	62	188	sd	sd	NOUN
gra-1415	62	189	)	)	PUNCT
gra-1415	62	190	,	,	PUNCT
gra-1415	62	191	unless	unless	SCONJ
gra-1415	62	192	otherwise	otherwise	ADV
gra-1415	62	193	specied	specied	PROPN
gra-1415	62	194	.	.	PROPN
gra-1415	62	195	bmi	bmi	PROPN
gra-1415	62	196	,	,	PUNCT
gra-1415	62	197	body	body	NOUN
gra-1415	62	198	mass	mass	PROPN
gra-1415	62	199	index	index	NOUN
gra-1415	62	200	;	;	PUNCT
gra-1415	62	201	bp	bp	PROPN
gra-1415	62	202	,	,	PUNCT
gra-1415	62	203	blood	blood	NOUN
gra-1415	62	204	pressure	pressure	NOUN
gra-1415	62	205	parameters	parameter	NOUN
gra-1415	62	206	group	group	NOUN
gra-1415	62	207	1	1	NUM
gra-1415	62	208	(	(	PUNCT
gra-1415	62	209	n=65	n=65	NOUN
gra-1415	62	210	)	)	PUNCT
gra-1415	62	211	group	group	NOUN
gra-1415	62	212	2	2	NUM
gra-1415	62	213	(	(	PUNCT
gra-1415	62	214	n=22	n=22	NOUN
gra-1415	62	215	)	)	PUNCT
gra-1415	62	216	p	p	NOUN
gra-1415	62	217	value	value	NOUN
gra-1415	62	218	age	age	NOUN
gra-1415	62	219	53.66	53.66	NUM
gra-1415	62	220	(	(	PUNCT
gra-1415	62	221	12.24	12.24	NUM
gra-1415	62	222	)	)	PUNCT
gra-1415	62	223	50.36	50.36	NUM
gra-1415	62	224	(	(	PUNCT
gra-1415	62	225	13.77	13.77	NUM
gra-1415	62	226	)	)	PUNCT
gra-1415	62	227	0.293	0.293	NUM
gra-1415	62	228	sex	sex	NOUN
gra-1415	62	229	,	,	PUNCT
gra-1415	62	230	n	n	CCONJ
gra-1415	62	231	(	(	PUNCT
gra-1415	62	232	%	%	INTJ
gra-1415	62	233	)	)	PUNCT
gra-1415	62	234	male	male	ADJ
gra-1415	62	235	female	female	NOUN
gra-1415	62	236	39	39	NUM
gra-1415	62	237	(	(	PUNCT
gra-1415	62	238	60	60	NUM
gra-1415	62	239	)	)	PUNCT
gra-1415	62	240	26	26	NUM
gra-1415	62	241	(	(	PUNCT
gra-1415	62	242	40	40	NUM
gra-1415	62	243	)	)	PUNCT
gra-1415	62	244	16	16	NUM
gra-1415	62	245	(	(	PUNCT
gra-1415	62	246	72.7	72.7	NUM
gra-1415	62	247	)	)	PUNCT
gra-1415	62	248	6	6	NUM
gra-1415	62	249	(	(	PUNCT
gra-1415	62	250	27.3	27.3	NUM
gra-1415	62	251	)	)	PUNCT
gra-1415	62	252	0.319	0.319	NUM
gra-1415	62	253	bmi	bmi	NOUN
gra-1415	62	254	22.44	22.44	NUM
gra-1415	62	255	(	(	PUNCT
gra-1415	62	256	3.33	3.33	NUM
gra-1415	62	257	)	)	PUNCT
gra-1415	62	258	23.55	23.55	NUM
gra-1415	62	259	(	(	PUNCT
gra-1415	62	260	3.28	3.28	NUM
gra-1415	62	261	)	)	PUNCT
gra-1415	62	262	0.177	0.177	NUM
gra-1415	62	263	vascular	vascular	ADJ
gra-1415	62	264	age	age	NOUN
gra-1415	62	265	,	,	PUNCT
gra-1415	62	266	n	n	CCONJ
gra-1415	62	267	(	(	PUNCT
gra-1415	62	268	%	%	INTJ
gra-1415	62	269	)	)	PUNCT
gra-1415	62	270	normal	normal	ADJ
gra-1415	62	271	average	average	ADJ
gra-1415	62	272	abnormal	abnormal	ADJ
gra-1415	62	273	27	27	NUM
gra-1415	62	274	(	(	PUNCT
gra-1415	62	275	42.2	42.2	NUM
gra-1415	62	276	)	)	PUNCT
gra-1415	62	277	21	21	NUM
gra-1415	62	278	(	(	PUNCT
gra-1415	62	279	32.8	32.8	NUM
gra-1415	62	280	)	)	PUNCT
gra-1415	62	281	16	16	NUM
gra-1415	62	282	(	(	PUNCT
gra-1415	62	283	25	25	NUM
gra-1415	62	284	)	)	PUNCT
gra-1415	62	285	7	7	NUM
gra-1415	62	286	(	(	PUNCT
gra-1415	62	287	31.8	31.8	NUM
gra-1415	62	288	)	)	PUNCT
gra-1415	62	289	9	9	NUM
gra-1415	62	290	(	(	PUNCT
gra-1415	62	291	40.9	40.9	NUM
gra-1415	62	292	)	)	PUNCT
gra-1415	62	293	6	6	NUM
gra-1415	62	294	(	(	PUNCT
gra-1415	62	295	27.3	27.3	NUM
gra-1415	62	296	)	)	PUNCT
gra-1415	62	297	0.675	0.675	NUM
gra-1415	62	298	small	small	ADJ
gra-1415	62	299	arterial	arterial	NOUN
gra-1415	62	300	stiffness	stiffness	NOUN
gra-1415	62	301	,	,	PUNCT
gra-1415	62	302	n	n	PROPN
gra-1415	62	303	(	(	PUNCT
gra-1415	62	304	%	%	INTJ
gra-1415	62	305	)	)	PUNCT
gra-1415	62	306	37	37	NUM
gra-1415	62	307	(	(	PUNCT
gra-1415	62	308	56.9	56.9	NUM
gra-1415	62	309	)	)	PUNCT
gra-1415	62	310	23	23	NUM
gra-1415	62	311	(	(	PUNCT
gra-1415	62	312	35.4	35.4	NUM
gra-1415	62	313	)	)	PUNCT
gra-1415	62	314	5	5	NUM
gra-1415	62	315	(	(	PUNCT
gra-1415	62	316	7.7	7.7	NUM
gra-1415	62	317	)	)	PUNCT
gra-1415	62	318	13	13	NUM
gra-1415	62	319	(	(	PUNCT
gra-1415	62	320	59.1	59.1	NUM
gra-1415	62	321	)	)	PUNCT
gra-1415	62	322	7	7	NUM
gra-1415	62	323	(	(	PUNCT
gra-1415	62	324	31.8	31.8	NUM
gra-1415	62	325	)	)	SYM
gra-1415	62	326	2	2	NUM
gra-1415	62	327	(	(	PUNCT
gra-1415	62	328	9.1	9.1	NUM
gra-1415	62	329	)	)	PUNCT
gra-1415	62	330	0.945normal	0.945normal	ADJ
gra-1415	62	331	average	average	ADJ
gra-1415	62	332	abnormal	abnormal	ADJ
gra-1415	62	333	large	large	ADJ
gra-1415	62	334	arterial	arterial	ADJ
gra-1415	62	335	stiffness	stiffness	NOUN
gra-1415	62	336	,	,	PUNCT
gra-1415	62	337	n	n	PROPN
gra-1415	62	338	(	(	PUNCT
gra-1415	62	339	%	%	INTJ
gra-1415	62	340	)	)	PUNCT
gra-1415	62	341	normal	normal	ADJ
gra-1415	62	342	18	18	NUM
gra-1415	62	343	(	(	PUNCT
gra-1415	62	344	27.7	27.7	NUM
gra-1415	62	345	)	)	PUNCT
gra-1415	62	346	7	7	NUM
gra-1415	62	347	(	(	PUNCT
gra-1415	62	348	31.8	31.8	NUM
gra-1415	62	349	)	)	PUNCT
gra-1415	62	350	average	average	NOUN
gra-1415	62	351	25	25	NUM
gra-1415	62	352	(	(	PUNCT
gra-1415	62	353	38.5	38.5	NUM
gra-1415	62	354	)	)	PUNCT
gra-1415	62	355	7	7	NUM
gra-1415	62	356	(	(	PUNCT
gra-1415	62	357	31.8	31.8	NUM
gra-1415	62	358	)	)	PUNCT
gra-1415	62	359	0.850	0.850	NUM
gra-1415	62	360	abnormal	abnormal	ADJ
gra-1415	62	361	22	22	NUM
gra-1415	62	362	(	(	PUNCT
gra-1415	62	363	33.8	33.8	NUM
gra-1415	62	364	)	)	SYM
gra-1415	62	365	8	8	NUM
gra-1415	62	366	(	(	PUNCT
gra-1415	62	367	36.4	36.4	NUM
gra-1415	62	368	)	)	PUNCT
gra-1415	62	369	peripheral	peripheral	ADJ
gra-1415	62	370	bp	bp	PROPN
gra-1415	62	371	systole	systole	PROPN
gra-1415	62	372	diastole	diastole	NOUN
gra-1415	62	373	128.35	128.35	NUM
gra-1415	62	374	(	(	PUNCT
gra-1415	62	375	20.81	20.81	NUM
gra-1415	62	376	)	)	PUNCT
gra-1415	62	377	87.92	87.92	NUM
gra-1415	62	378	(	(	PUNCT
gra-1415	62	379	14.15	14.15	NUM
gra-1415	62	380	)	)	PUNCT
gra-1415	62	381	132.77	132.77	NUM
gra-1415	62	382	(	(	PUNCT
gra-1415	62	383	15.50	15.50	NUM
gra-1415	62	384	)	)	PUNCT
gra-1415	62	385	86.31	86.31	NUM
gra-1415	62	386	(	(	PUNCT
gra-1415	62	387	10.20	10.20	NUM
gra-1415	62	388	)	)	PUNCT
gra-1415	62	389	0.364	0.364	NUM
gra-1415	62	390	0.626	0.626	NUM
gra-1415	62	391	pulse	pulse	NOUN
gra-1415	62	392	pressure	pressure	NOUN
gra-1415	62	393	41.41	41.41	NUM
gra-1415	62	394	(	(	PUNCT
gra-1415	62	395	12.49	12.49	NUM
gra-1415	62	396	)	)	PUNCT
gra-1415	62	397	46.45	46.45	NUM
gra-1415	62	398	(	(	PUNCT
gra-1415	62	399	10.39	10.39	NUM
gra-1415	62	400	)	)	PUNCT
gra-1415	62	401	0.093	0.093	NUM
gra-1415	62	402	heart	heart	NOUN
gra-1415	62	403	rate	rate	NOUN
gra-1415	62	404	89.94	89.94	NUM
gra-1415	62	405	(	(	PUNCT
gra-1415	62	406	17.11	17.11	NUM
gra-1415	62	407	)	)	PUNCT
gra-1415	62	408	90.09	90.09	NUM
gra-1415	62	409	(	(	PUNCT
gra-1415	62	410	17.42	17.42	NUM
gra-1415	62	411	)	)	PUNCT
gra-1415	62	412	0.150	0.150	NUM
gra-1415	62	413	arterial	arterial	NOUN
gra-1415	62	414	bp	bp	PROPN
gra-1415	62	415	106.32	106.32	NUM
gra-1415	62	416	(	(	PUNCT
gra-1415	62	417	15.70	15.70	NUM
gra-1415	62	418	)	)	PUNCT
gra-1415	62	419	107.63	107.63	NUM
gra-1415	62	420	(	(	PUNCT
gra-1415	62	421	11.95	11.95	NUM
gra-1415	62	422	)	)	PUNCT
gra-1415	62	423	0.721	0.721	NUM
gra-1415	62	424	augmentation	augmentation	NOUN
gra-1415	62	425	index	index	NOUN
gra-1415	62	426	25.24	25.24	NUM
gra-1415	62	427	(	(	PUNCT
gra-1415	62	428	11.63	11.63	NUM
gra-1415	62	429	)	)	PUNCT
gra-1415	62	430	27.54	27.54	NUM
gra-1415	62	431	(	(	PUNCT
gra-1415	62	432	10.12	10.12	NUM
gra-1415	62	433	)	)	PUNCT
gra-1415	62	434	0.411	0.411	NUM
gra-1415	62	435	pulse	pulse	NOUN
gra-1415	62	436	wave	wave	NOUN
gra-1415	62	437	velocity	velocity	NOUN
gra-1415	62	438	7.88	7.88	NUM
gra-1415	62	439	(	(	PUNCT
gra-1415	62	440	1.64	1.64	NUM
gra-1415	62	441	)	)	PUNCT
gra-1415	62	442	7.70	7.70	NUM
gra-1415	62	443	(	(	PUNCT
gra-1415	62	444	1.69	1.69	NUM
gra-1415	62	445	)	)	PUNCT
gra-1415	62	446	0.656	0.656	NUM
gra-1415	62	447	central	central	PROPN
gra-1415	62	448	bp	bp	PROPN
gra-1415	62	449	systole	systole	PROPN
gra-1415	62	450	118.68	118.68	NUM
gra-1415	62	451	(	(	PUNCT
gra-1415	62	452	18.29	18.29	NUM
gra-1415	62	453	)	)	PUNCT
gra-1415	62	454	120.27	120.27	NUM
gra-1415	62	455	(	(	PUNCT
gra-1415	62	456	12.15	12.15	NUM
gra-1415	62	457	)	)	PUNCT
gra-1415	62	458	0.704	0.704	NUM
gra-1415	62	459	diastole	diastole	NOUN
gra-1415	62	460	86.48	86.48	NUM
gra-1415	62	461	(	(	PUNCT
gra-1415	62	462	25.50	25.50	NUM
gra-1415	62	463	)	)	PUNCT
gra-1415	62	464	88.54	88.54	NUM
gra-1415	62	465	(	(	PUNCT
gra-1415	62	466	10.52	10.52	NUM
gra-1415	62	467	)	)	PUNCT
gra-1415	62	468	0.713	0.713	NUM
gra-1415	62	469	data	datum	NOUN
gra-1415	62	470	shown	show	VERB
gra-1415	62	471	as	as	ADP
gra-1415	62	472	mean	mean	NOUN
gra-1415	62	473	(	(	PUNCT
gra-1415	62	474	sd	sd	NOUN
gra-1415	62	475	)	)	PUNCT
gra-1415	62	476	,	,	PUNCT
gra-1415	62	477	unless	unless	SCONJ
gra-1415	62	478	otherwise	otherwise	ADV
gra-1415	62	479	specied	specied	PROPN
gra-1415	62	480	.	.	PROPN
gra-1415	62	481	bmi	bmi	PROPN
gra-1415	62	482	,	,	PUNCT
gra-1415	62	483	body	body	NOUN
gra-1415	62	484	mass	mass	PROPN
gra-1415	62	485	index	index	NOUN
gra-1415	62	486	;	;	PUNCT
gra-1415	62	487	bp	bp	PROPN
gra-1415	62	488	,	,	PUNCT
gra-1415	62	489	blood	blood	NOUN
gra-1415	62	490	pressure	pressure	NOUN
gra-1415	62	491	malleshappa	malleshappa	PROPN
gra-1415	62	492	p.	p.	PROPN
gra-1415	62	493	revealed	reveal	VERB
gra-1415	62	494	that	that	SCONJ
gra-1415	62	495	urinary	urinary	ADJ
gra-1415	62	496	albumin	albumin	ADJ
gra-1415	62	497	excretion	excretion	NOUN
gra-1415	62	498	was	be	AUX
gra-1415	62	499	signicantly	signicantly	ADV
gra-1415	62	500	reduced	reduce	VERB
gra-1415	62	501	by	by	ADP
gra-1415	62	502	administration	administration	NOUN
gra-1415	62	503	of	of	ADP
gra-1415	62	504	the	the	DET
gra-1415	62	505	cilnidipine	cilnidipine	NOUN
gra-1415	62	506	in	in	ADP
gra-1415	62	507	hypertensive	hypertensive	ADJ
gra-1415	62	508	ckd	ckd	NOUN
gra-1415	62	509	patients	patient	NOUN
gra-1415	63	1	[	[	X
gra-1415	63	2	13	13	NUM
gra-1415	63	3	]	]	PUNCT
gra-1415	63	4	.	.	PUNCT
gra-1415	64	1	he	he	PRON
gra-1415	64	2	also	also	ADV
gra-1415	64	3	suggested	suggest	VERB
gra-1415	64	4	that	that	SCONJ
gra-1415	64	5	early	early	ADJ
gra-1415	64	6	treatment	treatment	NOUN
gra-1415	64	7	of	of	ADP
gra-1415	64	8	cilnidipine	cilnidipine	NOUN
gra-1415	64	9	in	in	ADP
gra-1415	64	10	hypertensive	hypertensive	ADJ
gra-1415	64	11	ckd	ckd	NOUN
gra-1415	64	12	patients	patient	NOUN
gra-1415	64	13	with	with	ADP
gra-1415	64	14	lowgrade	lowgrade	NOUN
gra-1415	64	15	albuminuria	albuminuria	NOUN
gra-1415	64	16	may	may	AUX
gra-1415	64	17	prevent	prevent	VERB
gra-1415	64	18	cardiovascular	cardiovascular	ADJ
gra-1415	64	19	disease	disease	NOUN
gra-1415	64	20	.	.	PUNCT
gra-1415	65	1	a	a	DET
gra-1415	65	2	prospective	prospective	ADJ
gra-1415	65	3	randomized	randomized	ADJ
gra-1415	65	4	trial	trial	NOUN
gra-1415	65	5	demonstrated	demonstrate	VERB
gra-1415	65	6	by	by	ADP
gra-1415	65	7	zaman	zaman	PROPN
gra-1415	65	8	et	et	PROPN
gra-1415	65	9	al	al	PROPN
gra-1415	65	10	.	.	PROPN
gra-1415	65	11	compared	compare	VERB
gra-1415	65	12	the	the	DET
gra-1415	65	13	effects	effect	NOUN
gra-1415	65	14	of	of	ADP
gra-1415	65	15	amlodipine	amlodipine	NOUN
gra-1415	65	16	and	and	CCONJ
gra-1415	65	17	cilnidipine	cilnidipine	NOUN
gra-1415	65	18	on	on	ADP
gra-1415	65	19	blood	blood	NOUN
gra-1415	65	20	pressure	pressure	NOUN
gra-1415	65	21	,	,	PUNCT
gra-1415	65	22	heart	heart	NOUN
gra-1415	65	23	rate	rate	NOUN
gra-1415	65	24	,	,	PUNCT
gra-1415	65	25	proteinuria	proteinuria	NOUN
gra-1415	65	26	,	,	PUNCT
gra-1415	65	27	and	and	CCONJ
gra-1415	65	28	lipid	lipid	NOUN
gra-1415	65	29	prole	prole	PROPN
gra-1415	65	30	in	in	ADP
gra-1415	65	31	hypertensive	hypertensive	ADJ
gra-1415	65	32	patients	patient	NOUN
gra-1415	65	33	[	[	X
gra-1415	65	34	10	10	NUM
gra-1415	65	35	]	]	PUNCT
gra-1415	65	36	.	.	PUNCT
gra-1415	66	1	both	both	CCONJ
gra-1415	66	2	the	the	DET
gra-1415	66	3	drugs	drug	NOUN
gra-1415	66	4	showed	show	VERB
gra-1415	66	5	signicantly	signicantly	ADV
gra-1415	66	6	reduced	reduce	VERB
gra-1415	66	7	sbp	sbp	NOUN
gra-1415	66	8	and	and	CCONJ
gra-1415	66	9	dbp	dbp	PROPN
gra-1415	66	10	.	.	PUNCT
gra-1415	67	1	unlike	unlike	ADP
gra-1415	67	2	amlodipine	amlodipine	NOUN
gra-1415	67	3	,	,	PUNCT
gra-1415	67	4	pulse	pulse	NOUN
gra-1415	67	5	rate	rate	NOUN
gra-1415	67	6	and	and	CCONJ
gra-1415	67	7	urinary	urinary	ADJ
gra-1415	67	8	protein	protein	NOUN
gra-1415	67	9	excretion	excretion	NOUN
gra-1415	67	10	were	be	AUX
gra-1415	67	11	decreased	decrease	VERB
gra-1415	67	12	in	in	ADP
gra-1415	67	13	cilnidipine	cilnidipine	ADJ
gra-1415	67	14	group	group	NOUN
gra-1415	67	15	.	.	PUNCT
gra-1415	68	1	also	also	ADV
gra-1415	68	2	,	,	PUNCT
gra-1415	68	3	in	in	ADP
gra-1415	68	4	cilnidipine	cilnidipine	ADJ
gra-1415	68	5	group	group	NOUN
gra-1415	68	6	patients	patient	NOUN
gra-1415	68	7	with	with	ADP
gra-1415	68	8	diabetes	diabetes	NOUN
gra-1415	68	9	showed	show	VERB
gra-1415	68	10	reduce	reduce	VERB
gra-1415	68	11	serum	serum	NOUN
gra-1415	68	12	triglyceride	triglyceride	ADV
gra-1415	68	13	.	.	PUNCT
gra-1415	69	1	a	a	DET
gra-1415	69	2	multi	multi	ADJ
gra-1415	69	3	-	-	ADJ
gra-1415	69	4	centre	centre	ADJ
gra-1415	69	5	study	study	NOUN
gra-1415	69	6	at	at	ADP
gra-1415	69	7	japan	japan	PROPN
gra-1415	69	8	demonstrated	demonstrate	VERB
gra-1415	69	9	that	that	SCONJ
gra-1415	69	10	cilnidipine	cilnidipine	PROPN
gra-1415	69	11	had	have	VERB
gra-1415	69	12	greater	great	ADJ
gra-1415	69	13	antiproteinuric	antiproteinuric	ADJ
gra-1415	69	14	effects	effect	NOUN
gra-1415	69	15	than	than	ADP
gra-1415	69	16	amlodipine	amlodipine	NOUN
gra-1415	69	17	when	when	SCONJ
gra-1415	69	18	used	use	VERB
gra-1415	69	19	in	in	ADP
gra-1415	69	20	combination	combination	NOUN
gra-1415	69	21	with	with	ADP
gra-1415	69	22	a	a	DET
gra-1415	69	23	renin	renin	ADJ
gra-1415	69	24	-	-	PUNCT
gra-1415	69	25	angiotensin	angiotensin	NOUN
gra-1415	69	26	system	system	NOUN
gra-1415	69	27	(	(	PUNCT
gra-1415	69	28	ras	ras	NOUN
gra-1415	69	29	)	)	PUNCT
gra-1415	69	30	inhibitor	inhibitor	NOUN
gra-1415	69	31	to	to	PART
gra-1415	69	32	treat	treat	VERB
gra-1415	69	33	hypertensive	hypertensive	ADJ
gra-1415	69	34	patients	patient	NOUN
gra-1415	69	35	[	[	X
gra-1415	69	36	14	14	NUM
gra-1415	69	37	]	]	PUNCT
gra-1415	69	38	.	.	PUNCT
gra-1415	70	1	therefore	therefore	ADV
gra-1415	70	2	,	,	PUNCT
gra-1415	70	3	cilnidipine	cilnidipine	PROPN
gra-1415	70	4	showed	show	VERB
gra-1415	70	5	higher	high	ADJ
gra-1415	70	6	antioxidant	antioxidant	ADJ
gra-1415	70	7	activity	activity	NOUN
gra-1415	70	8	than	than	ADP
gra-1415	70	9	amlodipine	amlodipine	NOUN
gra-1415	70	10	when	when	SCONJ
gra-1415	70	11	used	use	VERB
gra-1415	70	12	in	in	ADP
gra-1415	70	13	combination	combination	NOUN
gra-1415	70	14	therapy	therapy	NOUN
gra-1415	70	15	.	.	PUNCT
gra-1415	71	1	similar	similar	ADJ
gra-1415	71	2	study	study	NOUN
gra-1415	71	3	done	do	VERB
gra-1415	71	4	by	by	ADP
gra-1415	71	5	fujita	fujita	PROPN
gra-1415	71	6	et	et	PROPN
gra-1415	71	7	al	al	PROPN
gra-1415	71	8	.	.	PROPN
gra-1415	71	9	showed	show	VERB
gra-1415	71	10	superior	superior	ADJ
gra-1415	71	11	effect	effect	NOUN
gra-1415	71	12	of	of	ADP
gra-1415	71	13	cilnidipine	cilnidipine	NOUN
gra-1415	71	14	in	in	ADP
gra-1415	71	15	preventing	prevent	VERB
gra-1415	71	16	progression	progression	NOUN
gra-1415	71	17	of	of	ADP
gra-1415	71	18	proteinuria	proteinuria	PROPN
gra-1415	71	19	more	more	ADV
gra-1415	71	20	potently	potently	ADV
gra-1415	71	21	than	than	ADP
gra-1415	71	22	that	that	PRON
gra-1415	71	23	with	with	ADP
gra-1415	71	24	amlodipine	amlodipine	NOUN
gra-1415	71	25	in	in	ADP
gra-1415	71	26	hypertensive	hypertensive	ADJ
gra-1415	71	27	ckd	ckd	NOUN
gra-1415	71	28	patients	patient	NOUN
gra-1415	71	29	concomitantly	concomitantly	ADV
gra-1415	71	30	with	with	ADP
gra-1415	71	31	ras	ras	PROPN
gra-1415	71	32	therapy	therapy	NOUN
gra-1415	71	33	[	[	X
gra-1415	71	34	11	11	NUM
gra-1415	71	35	]	]	PUNCT
gra-1415	71	36	.	.	PUNCT
gra-1415	72	1	a	a	DET
gra-1415	72	2	randomized	randomized	ADJ
gra-1415	72	3	trial	trial	NOUN
gra-1415	72	4	conducted	conduct	VERB
gra-1415	72	5	in	in	ADP
gra-1415	72	6	hypertensive	hypertensive	ADJ
gra-1415	72	7	patients	patient	NOUN
gra-1415	72	8	with	with	ADP
gra-1415	72	9	ckd	ckd	PROPN
gra-1415	72	10	reported	report	VERB
gra-1415	72	11	reduction	reduction	NOUN
gra-1415	72	12	of	of	ADP
gra-1415	72	13	ambulatory	ambulatory	ADJ
gra-1415	72	14	blood	blood	NOUN
gra-1415	72	15	pressure	pressure	NOUN
gra-1415	72	16	and	and	CCONJ
gra-1415	72	17	heart	heart	NOUN
gra-1415	72	18	rate	rate	NOUN
gra-1415	72	19	in	in	ADP
gra-1415	72	20	the	the	DET
gra-1415	72	21	cilnidipine	cilnidipine	ADJ
gra-1415	72	22	group	group	NOUN
gra-1415	72	23	compared	compare	VERB
gra-1415	72	24	with	with	ADP
gra-1415	72	25	the	the	DET
gra-1415	72	26	control	control	PROPN
gra-1415	72	27	ccbs	ccbs	PROPN
gra-1415	72	28	group	group	NOUN
gra-1415	72	29	.	.	PUNCT
gra-1415	73	1	furthermore	furthermore	ADV
gra-1415	73	2	,	,	PUNCT
gra-1415	73	3	the	the	DET
gra-1415	73	4	results	result	NOUN
gra-1415	73	5	showed	show	VERB
gra-1415	73	6	that	that	SCONJ
gra-1415	73	7	cilnidipine	cilnidipine	NOUN
gra-1415	73	8	is	be	AUX
gra-1415	73	9	superior	superior	ADJ
gra-1415	73	10	to	to	ADP
gra-1415	73	11	the	the	DET
gra-1415	73	12	control	control	NOUN
gra-1415	73	13	ccbs	ccbs	PROPN
gra-1415	73	14	in	in	ADP
gra-1415	73	15	improving	improve	VERB
gra-1415	73	16	left	leave	VERB
gra-1415	73	17	ventricular	ventricular	ADJ
gra-1415	73	18	hypertrophy	hypertrophy	NOUN
gra-1415	73	19	[	[	X
gra-1415	73	20	15	15	NUM
gra-1415	73	21	]	]	PUNCT
gra-1415	73	22	.	.	PUNCT
gra-1415	74	1	one	one	NUM
gra-1415	74	2	open	open	ADJ
gra-1415	74	3	labeled	label	VERB
gra-1415	74	4	study	study	NOUN
gra-1415	74	5	evaluated	evaluate	VERB
gra-1415	74	6	the	the	DET
gra-1415	74	7	effects	effect	NOUN
gra-1415	74	8	of	of	ADP
gra-1415	74	9	amlodipine	amlodipine	NOUN
gra-1415	74	10	and	and	CCONJ
gra-1415	74	11	cilnidipine	cilnidipine	NOUN
gra-1415	74	12	on	on	ADP
gra-1415	74	13	pwv	pwv	NOUN
gra-1415	74	14	and	and	CCONJ
gra-1415	74	15	augmentation	augmentation	NOUN
gra-1415	74	16	pressures	pressure	NOUN
gra-1415	74	17	in	in	ADP
gra-1415	74	18	hypertensive	hypertensive	ADJ
gra-1415	74	19	patients	patient	NOUN
gra-1415	74	20	[	[	X
gra-1415	74	21	9	9	NUM
gra-1415	74	22	]	]	PUNCT
gra-1415	74	23	.	.	PUNCT
gra-1415	75	1	cilnidipine	cilnidipine	PROPN
gra-1415	75	2	showed	show	VERB
gra-1415	75	3	signicantly	signicantly	ADV
gra-1415	75	4	higher	high	ADJ
gra-1415	75	5	improvement	improvement	NOUN
gra-1415	75	6	in	in	ADP
gra-1415	75	7	aortic	aortic	ADJ
gra-1415	75	8	blood	blood	NOUN
gra-1415	75	9	pressure	pressure	NOUN
gra-1415	75	10	and	and	CCONJ
gra-1415	75	11	aortic	aortic	ADJ
gra-1415	75	12	augmentation	augmentation	NOUN
gra-1415	75	13	pressure	pressure	NOUN
gra-1415	75	14	as	as	ADV
gra-1415	75	15	well	well	ADV
gra-1415	75	16	as	as	ADP
gra-1415	75	17	markers	marker	NOUN
gra-1415	75	18	of	of	ADP
gra-1415	75	19	arterial	arterial	ADJ
gra-1415	75	20	stiffness	stiffness	NOUN
gra-1415	75	21	including	include	VERB
gra-1415	75	22	pwv	pwv	NOUN
gra-1415	75	23	and	and	CCONJ
gra-1415	75	24	augmentation	augmentation	NOUN
gra-1415	75	25	index	index	NOUN
gra-1415	75	26	compared	compare	VERB
gra-1415	75	27	with	with	ADP
gra-1415	75	28	amlodipine	amlodipine	NOUN
gra-1415	75	29	.	.	PUNCT
gra-1415	76	1	however	however	ADV
gra-1415	76	2	,	,	PUNCT
gra-1415	76	3	this	this	DET
gra-1415	76	4	study	study	NOUN
gra-1415	76	5	showed	show	VERB
gra-1415	76	6	that	that	SCONJ
gra-1415	76	7	the	the	DET
gra-1415	76	8	cilnidipine	cilnidipine	NOUN
gra-1415	76	9	has	have	VERB
gra-1415	76	10	a	a	DET
gra-1415	76	11	similar	similar	ADJ
gra-1415	76	12	antihypertensive	antihypertensive	ADJ
gra-1415	76	13	action	action	NOUN
gra-1415	76	14	to	to	ADP
gra-1415	76	15	the	the	DET
gra-1415	76	16	amlodipine	amlodipine	NOUN
gra-1415	76	17	,	,	PUNCT
gra-1415	76	18	but	but	CCONJ
gra-1415	76	19	is	be	AUX
gra-1415	76	20	superior	superior	ADJ
gra-1415	76	21	in	in	ADP
gra-1415	76	22	terms	term	NOUN
gra-1415	76	23	of	of	ADP
gra-1415	76	24	improving	improve	VERB
gra-1415	76	25	arterial	arterial	ADJ
gra-1415	76	26	stiffness	stiffness	NOUN
gra-1415	76	27	and	and	CCONJ
gra-1415	76	28	central	central	ADJ
gra-1415	76	29	aortic	aortic	ADJ
gra-1415	76	30	pressures	pressure	NOUN
gra-1415	76	31	.	.	PUNCT
gra-1415	77	1	the	the	DET
gra-1415	77	2	present	present	ADJ
gra-1415	77	3	study	study	NOUN
gra-1415	77	4	assessed	assess	VERB
gra-1415	77	5	hemodynamic	hemodynamic	ADJ
gra-1415	77	6	parameters	parameter	NOUN
gra-1415	77	7	of	of	ADP
gra-1415	77	8	central	central	ADJ
gra-1415	77	9	blood	blood	NOUN
gra-1415	77	10	pressure	pressure	NOUN
gra-1415	77	11	and	and	CCONJ
gra-1415	77	12	arterial	arterial	ADJ
gra-1415	77	13	stiffness	stiffness	NOUN
gra-1415	77	14	in	in	ADP
gra-1415	77	15	ckd	ckd	NOUN
gra-1415	77	16	patients	patient	NOUN
gra-1415	77	17	associated	associate	VERB
gra-1415	77	18	with	with	ADP
gra-1415	77	19	hypertension	hypertension	NOUN
gra-1415	77	20	using	use	VERB
gra-1415	77	21	cilnidipine	cilnidipine	NOUN
gra-1415	77	22	and	and	CCONJ
gra-1415	77	23	amlodipine	amlodipine	NOUN
gra-1415	77	24	.	.	PUNCT
gra-1415	78	1	however	however	ADV
gra-1415	78	2	,	,	PUNCT
gra-1415	78	3	there	there	PRON
gra-1415	78	4	was	be	VERB
gra-1415	78	5	no	no	DET
gra-1415	78	6	signicant	signicant	ADJ
gra-1415	78	7	difference	difference	NOUN
gra-1415	78	8	in	in	ADP
gra-1415	78	9	the	the	DET
gra-1415	78	10	markers	marker	NOUN
gra-1415	78	11	of	of	ADP
gra-1415	78	12	arterial	arterial	ADJ
gra-1415	78	13	stiffness	stiffness	NOUN
gra-1415	78	14	and	and	CCONJ
gra-1415	78	15	central	central	ADJ
gra-1415	78	16	blood	blood	NOUN
gra-1415	78	17	pressure	pressure	NOUN
gra-1415	78	18	between	between	ADP
gra-1415	78	19	both	both	DET
gra-1415	78	20	the	the	DET
gra-1415	78	21	groups	group	NOUN
gra-1415	78	22	.	.	PUNCT
gra-1415	79	1	both	both	PRON
gra-1415	79	2	cilnidipine	cilnidipine	ADJ
gra-1415	79	3	and	and	CCONJ
gra-1415	79	4	amlodipine	amlodipine	NOUN
gra-1415	79	5	have	have	AUX
gra-1415	79	6	shown	show	VERB
gra-1415	79	7	similar	similar	ADJ
gra-1415	79	8	effect	effect	NOUN
gra-1415	79	9	in	in	ADP
gra-1415	79	10	reducing	reduce	VERB
gra-1415	79	11	blood	blood	NOUN
gra-1415	79	12	pressure	pressure	NOUN
gra-1415	79	13	in	in	ADP
gra-1415	79	14	patients	patient	NOUN
gra-1415	79	15	with	with	ADP
gra-1415	79	16	ckd	ckd	PROPN
gra-1415	79	17	and	and	CCONJ
gra-1415	79	18	associated	associate	VERB
gra-1415	79	19	with	with	ADP
gra-1415	79	20	hypertension	hypertension	NOUN
gra-1415	79	21	.	.	PUNCT
gra-1415	80	1	the	the	DET
gra-1415	80	2	present	present	ADJ
gra-1415	80	3	study	study	NOUN
gra-1415	80	4	has	have	VERB
gra-1415	80	5	several	several	ADJ
gra-1415	80	6	limitations	limitation	NOUN
gra-1415	80	7	.	.	PUNCT
gra-1415	81	1	firstly	firstly	ADV
gra-1415	81	2	,	,	PUNCT
gra-1415	81	3	small	small	ADJ
gra-1415	81	4	sample	sample	NOUN
gra-1415	81	5	size	size	NOUN
gra-1415	81	6	which	which	PRON
gra-1415	81	7	may	may	AUX
gra-1415	81	8	limit	limit	VERB
gra-1415	81	9	the	the	DET
gra-1415	81	10	determination	determination	NOUN
gra-1415	81	11	of	of	ADP
gra-1415	81	12	signicant	signicant	ADJ
gra-1415	81	13	effectiveness	effectiveness	NOUN
gra-1415	81	14	of	of	ADP
gra-1415	81	15	drugs	drug	NOUN
gra-1415	81	16	.	.	PUNCT
gra-1415	82	1	secondly	secondly	ADV
gra-1415	82	2	,	,	PUNCT
gra-1415	82	3	this	this	DET
gra-1415	82	4	study	study	NOUN
gra-1415	82	5	could	could	AUX
gra-1415	82	6	not	not	PART
gra-1415	82	7	evaluate	evaluate	VERB
gra-1415	82	8	the	the	DET
gra-1415	82	9	levels	level	NOUN
gra-1415	82	10	of	of	ADP
gra-1415	82	11	hemodynamic	hemodynamic	ADJ
gra-1415	82	12	and	and	CCONJ
gra-1415	82	13	vascular	vascular	ADJ
gra-1415	82	14	parameters	parameter	NOUN
gra-1415	82	15	before	before	ADP
gra-1415	82	16	and	and	CCONJ
gra-1415	82	17	after	after	ADP
gra-1415	82	18	the	the	DET
gra-1415	82	19	antihypertensive	antihypertensive	ADJ
gra-1415	82	20	drug	drug	NOUN
gra-1415	82	21	treatment	treatment	NOUN
gra-1415	82	22	in	in	ADP
gra-1415	82	23	the	the	DET
gra-1415	82	24	patients	patient	NOUN
gra-1415	82	25	with	with	ADP
gra-1415	82	26	ckd	ckd	PROPN
gra-1415	82	27	and	and	CCONJ
gra-1415	82	28	associated	associate	VERB
gra-1415	82	29	with	with	ADP
gra-1415	82	30	hypertension	hypertension	NOUN
gra-1415	82	31	which	which	PRON
gra-1415	82	32	could	could	AUX
gra-1415	82	33	have	have	AUX
gra-1415	82	34	added	add	VERB
gra-1415	82	35	a	a	DET
gra-1415	82	36	value	value	NOUN
gra-1415	82	37	to	to	ADP
gra-1415	82	38	the	the	DET
gra-1415	82	39	study	study	NOUN
gra-1415	82	40	.	.	PUNCT
gra-1415	83	1	studies	study	NOUN
gra-1415	83	2	with	with	ADP
gra-1415	83	3	large	large	ADJ
gra-1415	83	4	sample	sample	NOUN
gra-1415	83	5	size	size	NOUN
gra-1415	83	6	are	be	AUX
gra-1415	83	7	required	require	VERB
gra-1415	83	8	to	to	ADP
gra-1415	83	9	conrm	conrm	PROPN
gra-1415	83	10	above	above	ADJ
gra-1415	83	11	results	result	NOUN
gra-1415	83	12	.	.	PUNCT
gra-1415	84	1	conclusion	conclusion	NOUN
gra-1415	84	2	both	both	CCONJ
gra-1415	84	3	amlodipine	amlodipine	NOUN
gra-1415	84	4	and	and	CCONJ
gra-1415	84	5	cilnidipine	cilnidipine	NOUN
gra-1415	84	6	have	have	AUX
gra-1415	84	7	shown	show	VERB
gra-1415	84	8	equal	equal	ADJ
gra-1415	84	9	efcacy	efcacy	NOUN
gra-1415	84	10	in	in	ADP
gra-1415	84	11	terms	term	NOUN
gra-1415	84	12	of	of	ADP
gra-1415	84	13	hemodynamic	hemodynamic	ADJ
gra-1415	84	14	parameters	parameter	NOUN
gra-1415	84	15	of	of	ADP
gra-1415	84	16	central	central	ADJ
gra-1415	84	17	blood	blood	NOUN
gra-1415	84	18	pressure	pressure	NOUN
gra-1415	84	19	and	and	CCONJ
gra-1415	84	20	arterial	arterial	ADJ
gra-1415	84	21	stiffness	stiffness	NOUN
gra-1415	84	22	in	in	ADP
gra-1415	84	23	patients	patient	NOUN
gra-1415	84	24	with	with	ADP
gra-1415	84	25	ckd	ckd	PROPN
gra-1415	84	26	on	on	ADP
gra-1415	84	27	dialysis	dialysis	NOUN
gra-1415	84	28	and	and	CCONJ
gra-1415	84	29	with	with	ADP
gra-1415	84	30	associated	associated	ADJ
gra-1415	84	31	hypertension	hypertension	NOUN
gra-1415	84	32	.	.	PUNCT
gra-1415	85	1	references	reference	NOUN
gra-1415	85	2	1	1	NUM
gra-1415	85	3	.	.	PUNCT
gra-1415	85	4	protogerou	protogerou	PROPN
gra-1415	85	5	,	,	PUNCT
gra-1415	85	6	a.	a.	NOUN
gra-1415	85	7	,	,	PUNCT
gra-1415	85	8	blacher	blacher	NOUN
gra-1415	85	9	,	,	PUNCT
gra-1415	85	10	j.	j.	PROPN
gra-1415	85	11	,	,	PUNCT
gra-1415	85	12	stergiou	stergiou	PROPN
gra-1415	85	13	,	,	PUNCT
gra-1415	85	14	g.	g.	PROPN
gra-1415	85	15	s.	s.	PROPN
gra-1415	85	16	,	,	PUNCT
gra-1415	85	17	achimastos	achimastos	PROPN
gra-1415	85	18	,	,	PUNCT
gra-1415	85	19	a.	a.	PROPN
gra-1415	85	20	,	,	PUNCT
gra-1415	85	21	&	&	CCONJ
gra-1415	85	22	safar	safar	PROPN
gra-1415	85	23	,	,	PUNCT
gra-1415	85	24	m.	m.	PROPN
gra-1415	85	25	e.	e.	PROPN
gra-1415	85	26	(	(	PUNCT
gra-1415	85	27	2009	2009	NUM
gra-1415	85	28	)	)	PUNCT
gra-1415	85	29	.	.	PUNCT
gra-1415	86	1	blood	blood	NOUN
gra-1415	86	2	pressure	pressure	NOUN
gra-1415	86	3	response	response	NOUN
gra-1415	86	4	under	under	ADP
gra-1415	86	5	chronic	chronic	ADJ
gra-1415	86	6	antihypertensive	antihypertensive	ADJ
gra-1415	86	7	drug	drug	NOUN
gra-1415	86	8	therapy	therapy	NOUN
gra-1415	86	9	:	:	PUNCT
gra-1415	86	10	the	the	DET
gra-1415	86	11	role	role	NOUN
gra-1415	86	12	of	of	ADP
gra-1415	86	13	aortic	aortic	ADJ
gra-1415	86	14	stiffness	stiffness	NOUN
gra-1415	86	15	in	in	ADP
gra-1415	86	16	the	the	DET
gra-1415	86	17	reason	reason	NOUN
gra-1415	86	18	(	(	PUNCT
gra-1415	86	19	preterax	preterax	NOUN
gra-1415	86	20	in	in	ADP
gra-1415	86	21	regression	regression	NOUN
gra-1415	86	22	of	of	ADP
gra-1415	86	23	arterial	arterial	ADJ
gra-1415	86	24	stiffness	stiffness	NOUN
gra-1415	86	25	in	in	ADP
gra-1415	86	26	a	a	DET
gra-1415	86	27	controlled	control	VERB
gra-1415	86	28	double	double	ADJ
gra-1415	86	29	-	-	PUNCT
gra-1415	86	30	blind	blind	ADJ
gra-1415	86	31	)	)	PUNCT
gra-1415	86	32	study	study	NOUN
gra-1415	86	33	.	.	PUNCT
gra-1415	87	1	j	j	PROPN
gra-1415	87	2	am	be	AUX
gra-1415	87	3	coll	coll	PROPN
gra-1415	87	4	cardiol	cardiol	PROPN
gra-1415	87	5	,	,	PUNCT
gra-1415	87	6	53(5	53(5	NUM
gra-1415	87	7	)	)	PUNCT
gra-1415	87	8	,	,	PUNCT
gra-1415	87	9	445	445	NUM
gra-1415	87	10	-	-	SYM
gra-1415	87	11	451	451	NUM
gra-1415	87	12	.	.	PUNCT
gra-1415	88	1	https://doi.org/	https://doi.org/	VERB
gra-1415	88	2	10.1016	10.1016	NUM
gra-1415	88	3	/	/	SYM
gra-1415	88	4	j.jacc.2008.09.046	j.jacc.2008.09.046	NOUN
gra-1415	89	1	2	2	NUM
gra-1415	89	2	.	.	PUNCT
gra-1415	90	1	nguyen	nguyen	PROPN
gra-1415	90	2	,	,	PUNCT
gra-1415	90	3	q.	q.	PROPN
gra-1415	90	4	,	,	PUNCT
gra-1415	90	5	dominguez	dominguez	PROPN
gra-1415	90	6	,	,	PUNCT
gra-1415	90	7	j.	j.	PROPN
gra-1415	90	8	,	,	PUNCT
gra-1415	90	9	nguyen	nguyen	PROPN
gra-1415	90	10	,	,	PUNCT
gra-1415	90	11	l.	l.	PROPN
gra-1415	90	12	,	,	PUNCT
gra-1415	90	13	&	&	CCONJ
gra-1415	90	14	gullapalli	gullapalli	PROPN
gra-1415	90	15	,	,	PUNCT
gra-1415	90	16	n.	n.	PROPN
gra-1415	90	17	(	(	PUNCT
gra-1415	90	18	2010	2010	NUM
gra-1415	90	19	)	)	PUNCT
gra-1415	90	20	.	.	PUNCT
gra-1415	91	1	hypertension	hypertension	NOUN
gra-1415	91	2	management	management	NOUN
gra-1415	91	3	:	:	PUNCT
gra-1415	91	4	an	an	DET
gra-1415	91	5	update	update	NOUN
gra-1415	91	6	.	.	PUNCT
gra-1415	92	1	am	be	AUX
gra-1415	92	2	health	health	NOUN
gra-1415	92	3	drug	drug	NOUN
gra-1415	92	4	benets	benets	PROPN
gra-1415	92	5	,	,	PUNCT
gra-1415	92	6	3(1	3(1	NUM
gra-1415	92	7	)	)	PUNCT
gra-1415	92	8	,	,	PUNCT
gra-1415	92	9	47–56	47–56	NUM
gra-1415	92	10	.	.	PUNCT
gra-1415	93	1	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4106550/	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4106550/	NOUN
gra-1415	93	2	3	3	NUM
gra-1415	93	3	.	.	PUNCT
gra-1415	93	4	safar	safar	PROPN
gra-1415	93	5	,	,	PUNCT
gra-1415	93	6	m.	m.	PROPN
gra-1415	93	7	e.	e.	PROPN
gra-1415	93	8	,	,	PUNCT
gra-1415	93	9	pannier	pannier	NOUN
gra-1415	93	10	,	,	PUNCT
gra-1415	93	11	b.	b.	PROPN
gra-1415	93	12	,	,	PUNCT
gra-1415	93	13	laurent	laurent	PROPN
gra-1415	93	14	,	,	PUNCT
gra-1415	93	15	s.	s.	PROPN
gra-1415	93	16	,	,	PUNCT
gra-1415	93	17	&	&	CCONJ
gra-1415	93	18	london	london	PROPN
gra-1415	93	19	,	,	PUNCT
gra-1415	93	20	g.	g.	PROPN
gra-1415	93	21	m.	m.	PROPN
gra-1415	93	22	(	(	PUNCT
gra-1415	93	23	1989	1989	NUM
gra-1415	93	24	)	)	PUNCT
gra-1415	93	25	.	.	PUNCT
gra-1415	94	1	calcium	calcium	NOUN
gra-1415	94	2	-	-	PUNCT
gra-1415	94	3	entry	entry	NOUN
gra-1415	94	4	blockers	blocker	NOUN
gra-1415	94	5	and	and	CCONJ
gra-1415	94	6	arterial	arterial	ADJ
gra-1415	94	7	compliance	compliance	NOUN
gra-1415	94	8	in	in	ADP
gra-1415	94	9	hypertension	hypertension	NOUN
gra-1415	94	10	.	.	PUNCT
gra-1415	95	1	j	j	PROPN
gra-1415	95	2	cardiovasc	cardiovasc	PROPN
gra-1415	95	3	pharmacol	pharmacol	PROPN
gra-1415	95	4	,	,	PUNCT
gra-1415	95	5	14(suppl	14(suppl	NUM
gra-1415	95	6	10	10	NUM
gra-1415	95	7	):	):	PUNCT
gra-1415	95	8	s1	s1	NOUN
gra-1415	95	9	-	-	PUNCT
gra-1415	95	10	6	6	NUM
gra-1415	95	11	,	,	PUNCT
gra-1415	95	12	discussion	discussion	NOUN
gra-1415	95	13	s59	s59	NOUN
gra-1415	95	14	-	-	PUNCT
gra-1415	95	15	62	62	NUM
gra-1415	95	16	.	.	PUNCT
gra-1415	96	1	https://doi.org/	https://doi.org/	VERB
gra-1415	96	2	10.1097/00005344198906151	10.1097/00005344198906151	NUM
gra-1415	96	3	-	-	PUNCT
gra-1415	96	4	00002	00002	NUM
gra-1415	96	5	4	4	NUM
gra-1415	96	6	.	.	PUNCT
gra-1415	97	1	kim	kim	PROPN
gra-1415	97	2	,	,	PUNCT
gra-1415	97	3	k.	k.	PROPN
gra-1415	97	4	h.	h.	PROPN
gra-1415	97	5	,	,	PUNCT
gra-1415	97	6	jeong	jeong	PROPN
gra-1415	97	7	,	,	PUNCT
gra-1415	97	8	m.	m.	PROPN
gra-1415	97	9	h.	h.	PROPN
gra-1415	97	10	,	,	PUNCT
gra-1415	97	11	cho	cho	PROPN
gra-1415	97	12	,	,	PUNCT
gra-1415	97	13	s.	s.	PROPN
gra-1415	97	14	h.	h.	PROPN
gra-1415	97	15	,	,	PUNCT
gra-1415	97	16	moon	moon	PROPN
gra-1415	97	17	,	,	PUNCT
gra-1415	97	18	j.y	j.y	PROPN
gra-1415	97	19	.	.	PROPN
gra-1415	97	20	,	,	PUNCT
gra-1415	97	21	hong	hong	PROPN
gra-1415	97	22	,	,	PUNCT
gra-1415	97	23	y.	y.	PROPN
gra-1415	97	24	j.	j.	PROPN
gra-1415	97	25	,	,	PUNCT
gra-1415	97	26	park	park	PROPN
gra-1415	97	27	,	,	PUNCT
gra-1415	97	28	h.	h.	PROPN
gra-1415	97	29	w.	w.	PROPN
gra-1415	97	30	,	,	PUNCT
gra-1415	97	31	kim	kim	PROPN
gra-1415	97	32	,	,	PUNCT
gra-1415	97	33	j.	j.	PROPN
gra-1415	97	34	h.	h.	PROPN
gra-1415	97	35	,	,	PUNCT
gra-1415	97	36	ahn	ahn	PROPN
gra-1415	97	37	,	,	PUNCT
gra-1415	97	38	y.	y.	PROPN
gra-1415	97	39	,	,	PUNCT
gra-1415	97	40	cho	cho	PROPN
gra-1415	97	41	,	,	PUNCT
gra-1415	97	42	j.	j.	PROPN
gra-1415	97	43	g.	g.	PROPN
gra-1415	97	44	,	,	PUNCT
gra-1415	97	45	park	park	PROPN
gra-1415	97	46	,	,	PUNCT
gra-1415	97	47	j.	j.	PROPN
gra-1415	97	48	c.	c.	PROPN
gra-1415	97	49	,	,	PUNCT
gra-1415	97	50	&	&	CCONJ
gra-1415	97	51	kang	kang	PROPN
gra-1415	97	52	,	,	PUNCT
gra-1415	97	53	j.	j.	PROPN
gra-1415	97	54	c.	c.	PROPN
gra-1415	97	55	(	(	PUNCT
gra-1415	97	56	2009	2009	NUM
gra-1415	97	57	)	)	PUNCT
gra-1415	97	58	.	.	PUNCT
gra-1415	98	1	clinical	clinical	ADJ
gra-1415	98	2	effects	effect	NOUN
gra-1415	98	3	of	of	ADP
gra-1415	98	4	calcium	calcium	NOUN
gra-1415	98	5	channel	channel	NOUN
gra-1415	98	6	blocker	blocker	NOUN
gra-1415	98	7	and	and	CCONJ
gra-1415	98	8	angiotensin	angiotensin	NOUN
gra-1415	98	9	converting	convert	VERB
gra-1415	98	10	enzyme	enzyme	NOUN
gra-1415	98	11	inhibitor	inhibitor	NOUN
gra-1415	98	12	on	on	ADP
gra-1415	98	13	endothelial	endothelial	ADJ
gra-1415	98	14	function	function	NOUN
gra-1415	98	15	and	and	CCONJ
gra-1415	98	16	arterial	arterial	ADJ
gra-1415	98	17	stiffness	stiffness	NOUN
gra-1415	98	18	in	in	ADP
gra-1415	98	19	patients	patient	NOUN
gra-1415	98	20	with	with	ADP
gra-1415	98	21	angina	angina	PROPN
gra-1415	98	22	pectoris	pectoris	PROPN
gra-1415	98	23	.	.	PUNCT
gra-1415	99	1	journal	journal	PROPN
gra-1415	99	2	of	of	ADP
gra-1415	99	3	korean	korean	PROPN
gra-1415	99	4	medical	medical	ADJ
gra-1415	99	5	science	science	NOUN
gra-1415	99	6	,	,	PUNCT
gra-1415	99	7	24(2	24(2	NUM
gra-1415	99	8	)	)	PUNCT
gra-1415	99	9	,	,	PUNCT
gra-1415	99	10	223	223	NUM
gra-1415	99	11	-	-	SYM
gra-1415	99	12	231	231	NUM
gra-1415	99	13	.	.	PUNCT
gra-1415	100	1	https://doi.org/	https://doi.org/	VERB
gra-1415	100	2	10.3346/	10.3346/	NUM
gra-1415	100	3	jkms	jkms	NOUN
gra-1415	100	4	.	.	PUNCT
gra-1415	101	1	2009.24.2.223	2009.24.2.223	NUM
gra-1415	101	2	5	5	NUM
gra-1415	101	3	.	.	PUNCT
gra-1415	102	1	takahara	takahara	NOUN
gra-1415	102	2	,	,	PUNCT
gra-1415	102	3	a.	a.	NOUN
gra-1415	102	4	(	(	PUNCT
gra-1415	102	5	2009	2009	NUM
gra-1415	102	6	)	)	PUNCT
gra-1415	102	7	.	.	PUNCT
gra-1415	103	1	cilnidipine	cilnidipine	NOUN
gra-1415	103	2	:	:	PUNCT
gra-1415	103	3	a	a	DET
gra-1415	103	4	new	new	ADJ
gra-1415	103	5	generation	generation	NOUN
gra-1415	103	6	ca	can	AUX
gra-1415	103	7	channel	channel	VERB
gra-1415	103	8	blocker	blocker	NOUN
gra-1415	103	9	with	with	ADP
gra-1415	103	10	inhibitory	inhibitory	ADJ
gra-1415	103	11	action	action	NOUN
gra-1415	103	12	on	on	ADP
gra-1415	103	13	sympathetic	sympathetic	ADJ
gra-1415	103	14	neurotransmitter	neurotransmitter	NOUN
gra-1415	103	15	release	release	NOUN
gra-1415	103	16	.	.	PUNCT
gra-1415	104	1	cardiovasc	cardiovasc	PROPN
gra-1415	104	2	ther	ther	ADV
gra-1415	104	3	,	,	PUNCT
gra-1415	104	4	27(2	27(2	PRON
gra-1415	104	5	)	)	PUNCT
gra-1415	104	6	,	,	PUNCT
gra-1415	104	7	124	124	NUM
gra-1415	104	8	-	-	SYM
gra-1415	104	9	139	139	NUM
gra-1415	104	10	.	.	PUNCT
gra-1415	105	1	https://doi.org/10.1111/j.1755-5922.2009.00079.x	https://doi.org/10.1111/j.1755-5922.2009.00079.x	ADV
gra-1415	105	2	6	6	NUM
gra-1415	105	3	.	.	X
gra-1415	106	1	babu	babu	PROPN
gra-1415	106	2	,	,	PUNCT
gra-1415	106	3	k.	k.	PROPN
gra-1415	106	4	a.	a.	PROPN
gra-1415	106	5	(	(	PUNCT
gra-1415	106	6	2017	2017	NUM
gra-1415	106	7	)	)	PUNCT
gra-1415	106	8	.	.	PUNCT
gra-1415	107	1	assessment	assessment	NOUN
gra-1415	107	2	of	of	ADP
gra-1415	107	3	efcacy	efcacy	NOUN
gra-1415	107	4	of	of	ADP
gra-1415	107	5	amlodipine	amlodipine	NOUN
gra-1415	107	6	with	with	ADP
gra-1415	107	7	cilnidipine	cilnidipine	NOUN
gra-1415	107	8	in	in	ADP
gra-1415	107	9	hypertensive	hypertensive	ADJ
gra-1415	107	10	patients	patient	NOUN
gra-1415	107	11	:	:	PUNCT
gra-1415	107	12	a	a	DET
gra-1415	107	13	comparative	comparative	ADJ
gra-1415	107	14	study	study	NOUN
gra-1415	107	15	.	.	PUNCT
gra-1415	108	1	int	int	PROPN
gra-1415	108	2	j	j	PROPN
gra-1415	108	3	contemporary	contemporary	ADJ
gra-1415	108	4	med	med	PROPN
gra-1415	108	5	research	research	NOUN
gra-1415	108	6	,	,	PUNCT
gra-1415	108	7	4(4	4(4	NUM
gra-1415	108	8	)	)	PUNCT
gra-1415	108	9	,	,	PUNCT
gra-1415	108	10	956	956	NUM
gra-1415	108	11	-	-	SYM
gra-1415	108	12	958	958	NUM
gra-1415	108	13	.	.	PUNCT
gra-1415	108	14	https://www.ijcmr.com/	https://www.ijcmr.com/	VERB
gra-1415	108	15	uploads/	uploads/	NUM
gra-1415	108	16	7/7/4/6/	7/7/4/6/	NUM
gra-1415	108	17	77464738/	77464738/	NUM
gra-1415	108	18	ijcmr_1416_may_20.pdf	ijcmr_1416_may_20.pdf	VERB
gra-1415	108	19	7	7	NUM
gra-1415	108	20	.	.	NOUN
gra-1415	108	21	adake	adake	NOUN
gra-1415	108	22	,	,	PUNCT
gra-1415	108	23	p.	p.	NOUN
gra-1415	108	24	,	,	PUNCT
gra-1415	108	25	somashekar	somashekar	PROPN
gra-1415	108	26	,	,	PUNCT
gra-1415	108	27	h.	h.	PROPN
gra-1415	108	28	s.	s.	PROPN
gra-1415	108	29	,	,	PUNCT
gra-1415	108	30	mohammed	mohammed	PROPN
gra-1415	108	31	rafeeq	rafeeq	NOUN
gra-1415	108	32	,	,	PUNCT
gra-1415	108	33	p.	p.	PROPN
gra-1415	108	34	k.	k.	PROPN
gra-1415	108	35	,	,	PUNCT
gra-1415	108	36	umar	umar	PROPN
gra-1415	108	37	d.	d.	PROPN
gra-1415	108	38	,	,	PUNCT
gra-1415	108	39	basheer	basheer	PROPN
gra-1415	108	40	,	,	PUNCT
gra-1415	108	41	b.	b.	PROPN
gra-1415	108	42	,	,	PUNCT
gra-1415	108	43	&	&	CCONJ
gra-1415	108	44	baroudi	baroudi	PROPN
gra-1415	108	45	,	,	PUNCT
gra-1415	108	46	k.	k.	PROPN
gra-1415	108	47	(	(	PUNCT
gra-1415	108	48	2015	2015	NUM
gra-1415	108	49	)	)	PUNCT
gra-1415	108	50	.	.	PUNCT
gra-1415	109	1	comparison	comparison	NOUN
gra-1415	109	2	of	of	ADP
gra-1415	109	3	amlodipine	amlodipine	NOUN
gra-1415	109	4	with	with	ADP
gra-1415	109	5	cilnidipine	cilnidipine	NOUN
gra-1415	109	6	on	on	ADP
gra-1415	109	7	antihypertensive	antihypertensive	ADJ
gra-1415	109	8	efcacy	efcacy	NOUN
gra-1415	109	9	and	and	CCONJ
gra-1415	109	10	incidence	incidence	NOUN
gra-1415	109	11	of	of	ADP
gra-1415	109	12	pedal	pedal	ADJ
gra-1415	109	13	edema	edema	NOUN
gra-1415	109	14	in	in	ADP
gra-1415	109	15	mild	mild	ADJ
gra-1415	109	16	to	to	ADP
gra-1415	109	17	moderate	moderate	ADJ
gra-1415	109	18	hypertensive	hypertensive	ADJ
gra-1415	109	19	individuals	individual	NOUN
gra-1415	109	20	:	:	PUNCT
gra-1415	109	21	a	a	DET
gra-1415	109	22	prospective	prospective	ADJ
gra-1415	109	23	study	study	NOUN
gra-1415	109	24	.	.	PUNCT
gra-1415	110	1	j	j	PROPN
gra-1415	110	2	adv	adv	PROPN
gra-1415	110	3	pharm	pharm	PROPN
gra-1415	110	4	technol	technol	PROPN
gra-1415	110	5	res	re	NOUN
gra-1415	110	6	,	,	PUNCT
gra-1415	110	7	6(2	6(2	NUM
gra-1415	110	8	)	)	PUNCT
gra-1415	110	9	,	,	PUNCT
gra-1415	110	10	81	81	NUM
gra-1415	110	11	-	-	SYM
gra-1415	110	12	85	85	NUM
gra-1415	110	13	.	.	PUNCT
gra-1415	111	1	https://doi.org/10.4103/2231-4040.154543	https://doi.org/10.4103/2231-4040.154543	PROPN
gra-1415	111	2	.	.	PUNCT
gra-1415	112	1	8	8	NUM
gra-1415	112	2	.	.	X
gra-1415	112	3	morimoto	morimoto	PROPN
gra-1415	112	4	,	,	PUNCT
gra-1415	112	5	s.	s.	PROPN
gra-1415	112	6	,	,	PUNCT
gra-1415	112	7	yano	yano	PROPN
gra-1415	112	8	,	,	PUNCT
gra-1415	112	9	y.	y.	PROPN
gra-1415	112	10	,	,	PUNCT
gra-1415	112	11	maki	maki	PROPN
gra-1415	112	12	,	,	PUNCT
gra-1415	112	13	k.	k.	PROPN
gra-1415	112	14	,	,	PUNCT
gra-1415	112	15	&	&	CCONJ
gra-1415	112	16	iwasaka	iwasaka	PROPN
gra-1415	112	17	,	,	PUNCT
gra-1415	112	18	t.	t.	PROPN
gra-1415	112	19	(	(	PUNCT
gra-1415	112	20	2007	2007	NUM
gra-1415	112	21	)	)	PUNCT
gra-1415	112	22	.	.	PUNCT
gra-1415	113	1	renal	renal	ADJ
gra-1415	113	2	and	and	CCONJ
gra-1415	113	3	vascular	vascular	ADJ
gra-1415	113	4	protective	protective	ADJ
gra-1415	113	5	effects	effect	NOUN
gra-1415	113	6	of	of	ADP
gra-1415	113	7	cilnidipine	cilnidipine	NOUN
gra-1415	113	8	in	in	ADP
gra-1415	113	9	patients	patient	NOUN
gra-1415	113	10	with	with	ADP
gra-1415	113	11	essential	essential	ADJ
gra-1415	113	12	hypertension	hypertension	NOUN
gra-1415	113	13	.	.	PUNCT
gra-1415	114	1	j	j	PROPN
gra-1415	114	2	hypertens	hyperten	NOUN
gra-1415	114	3	,	,	PUNCT
gra-1415	114	4	25(10	25(10	NOUN
gra-1415	114	5	)	)	PUNCT
gra-1415	114	6	,	,	PUNCT
gra-1415	114	7	2178	2178	NUM
gra-1415	114	8	-	-	SYM
gra-1415	114	9	2183	2183	NUM
gra-1415	114	10	.	.	PUNCT
gra-1415	115	1	https://doi.org/10.1097/hjh.0b013e3282c2fa62	https://doi.org/10.1097/hjh.0b013e3282c2fa62	NOUN
gra-1415	115	2	9	9	NUM
gra-1415	115	3	.	.	PUNCT
gra-1415	115	4	pathapati	pathapati	PROPN
gra-1415	115	5	,	,	PUNCT
gra-1415	115	6	r.	r.	PROPN
gra-1415	115	7	m.	m.	PROPN
gra-1415	115	8	,	,	PUNCT
gra-1415	115	9	rajashekar	rajashekar	PROPN
gra-1415	115	10	,	,	PUNCT
gra-1415	115	11	s.	s.	PROPN
gra-1415	115	12	t.	t.	PROPN
gra-1415	115	13	,	,	PUNCT
gra-1415	115	14	buchineni	buchineni	NOUN
gra-1415	115	15	,	,	PUNCT
gra-1415	115	16	m.	m.	NOUN
gra-1415	115	17	,	,	PUNCT
gra-1415	115	18	meriga	meriga	NOUN
gra-1415	115	19	,	,	PUNCT
gra-1415	115	20	r.	r.	PROPN
gra-1415	115	21	k.	k.	PROPN
gra-1415	115	22	,	,	PUNCT
gra-1415	115	23	reddy	reddy	PROPN
gra-1415	115	24	,	,	PUNCT
gra-1415	115	25	c.	c.	PROPN
gra-1415	115	26	b.	b.	PROPN
gra-1415	115	27	,	,	PUNCT
gra-1415	115	28	&	&	CCONJ
gra-1415	115	29	kumar	kumar	PROPN
gra-1415	115	30	,	,	PUNCT
gra-1415	115	31	k.	k.	PROPN
gra-1415	115	32	p.	p.	PROPN
gra-1415	115	33	(	(	PUNCT
gra-1415	115	34	2015	2015	NUM
gra-1415	115	35	)	)	PUNCT
gra-1415	115	36	.	.	PUNCT
gra-1415	116	1	an	an	DET
gra-1415	116	2	open	open	ADJ
gra-1415	116	3	label	label	NOUN
gra-1415	116	4	parallel	parallel	NOUN
gra-1415	116	5	group	group	NOUN
gra-1415	116	6	study	study	NOUN
gra-1415	116	7	to	to	PART
gra-1415	116	8	assess	assess	VERB
gra-1415	116	9	the	the	DET
gra-1415	116	10	effects	effect	NOUN
gra-1415	116	11	of	of	ADP
gra-1415	116	12	amlodipine	amlodipine	NOUN
gra-1415	116	13	and	and	CCONJ
gra-1415	116	14	cilnidipine	cilnidipine	NOUN
gra-1415	116	15	on	on	ADP
gra-1415	116	16	pulse	pulse	NOUN
gra-1415	116	17	wave	wave	NOUN
gra-1415	116	18	velocity	velocity	NOUN
gra-1415	116	19	and	and	CCONJ
gra-1415	116	20	augmentation	augmentation	NOUN
gra-1415	116	21	pressures	pressure	NOUN
gra-1415	116	22	in	in	ADP
gra-1415	116	23	mild	mild	ADJ
gra-1415	116	24	to	to	ADP
gra-1415	116	25	moderate	moderate	ADJ
gra-1415	116	26	essential	essential	ADJ
gra-1415	116	27	hypertensive	hypertensive	ADJ
gra-1415	116	28	patients	patient	NOUN
gra-1415	116	29	.	.	PUNCT
gra-1415	117	1	j	j	PROPN
gra-1415	117	2	clin	clin	PROPN
gra-1415	117	3	diagn	diagn	PROPN
gra-1415	117	4	res	re	NOUN
gra-1415	117	5	,	,	PUNCT
gra-1415	117	6	9(11	9(11	NUM
gra-1415	117	7	)	)	PUNCT
gra-1415	117	8	,	,	PUNCT
gra-1415	117	9	fc13	fc13	PROPN
gra-1415	117	10	-	-	PUNCT
gra-1415	117	11	6	6	NUM
gra-1415	117	12	.	.	PUNCT
gra-1415	118	1	https://doi.org/10.7860/jcdr/2015/12702.6754	https://doi.org/10.7860/jcdr/2015/12702.6754	PROPN
gra-1415	118	2	10	10	NUM
gra-1415	118	3	.	.	X
gra-1415	119	1	zaman	zaman	PROPN
gra-1415	119	2	,	,	PUNCT
gra-1415	119	3	z.	z.	PROPN
gra-1415	119	4	a.	a.	PROPN
gra-1415	119	5	,	,	PUNCT
gra-1415	119	6	&	&	CCONJ
gra-1415	119	7	kumari	kumari	PROPN
gra-1415	119	8	,	,	PUNCT
gra-1415	119	9	v.	v.	PROPN
gra-1415	119	10	(	(	PUNCT
gra-1415	119	11	2017	2017	NUM
gra-1415	119	12	)	)	PUNCT
gra-1415	119	13	.	.	PUNCT
gra-1415	120	1	comparison	comparison	NOUN
gra-1415	120	2	of	of	ADP
gra-1415	120	3	the	the	DET
gra-1415	120	4	effects	effect	NOUN
gra-1415	120	5	of	of	ADP
gra-1415	120	6	amlodipine	amlodipine	NOUN
gra-1415	120	7	and	and	CCONJ
gra-1415	120	8	cilnidipine	cilnidipine	NOUN
gra-1415	120	9	on	on	ADP
gra-1415	120	10	blood	blood	NOUN
gra-1415	120	11	pressure	pressure	NOUN
gra-1415	120	12	,	,	PUNCT
gra-1415	120	13	heart	heart	NOUN
gra-1415	120	14	rate	rate	NOUN
gra-1415	120	15	,	,	PUNCT
gra-1415	120	16	proteinuria	proteinuria	NOUN
gra-1415	120	17	and	and	CCONJ
gra-1415	120	18	lipid	lipid	NOUN
gra-1415	120	19	prole	prole	PROPN
gra-1415	120	20	in	in	ADP
gra-1415	120	21	hypertensive	hypertensive	ADJ
gra-1415	120	22	patients	patient	NOUN
gra-1415	120	23	.	.	PUNCT
gra-1415	121	1	int	int	PROPN
gra-1415	121	2	j	j	PROPN
gra-1415	121	3	basic	basic	ADJ
gra-1415	121	4	clin	clin	PROPN
gra-1415	121	5	pharmacol	pharmacol	PROPN
gra-1415	121	6	,	,	PUNCT
gra-1415	121	7	2(2	2(2	NUM
gra-1415	121	8	)	)	PUNCT
gra-1415	121	9	,	,	PUNCT
gra-1415	121	10	160	160	NUM
gra-1415	121	11	-	-	SYM
gra-1415	121	12	164	164	NUM
gra-1415	121	13	.	.	PUNCT
gra-1415	122	1	https://doi.org/10.5455/2319-2003.ijbcp20130308	https://doi.org/10.5455/2319-2003.ijbcp20130308	ADP
gra-1415	122	2	11	11	NUM
gra-1415	122	3	.	.	PUNCT
gra-1415	123	1	fujita	fujita	PROPN
gra-1415	123	2	,	,	PUNCT
gra-1415	123	3	t.	t.	PROPN
gra-1415	123	4	,	,	PUNCT
gra-1415	123	5	ando	ando	PROPN
gra-1415	123	6	,	,	PUNCT
gra-1415	123	7	k.	k.	PROPN
gra-1415	123	8	,	,	PUNCT
gra-1415	123	9	nishimura	nishimura	PROPN
gra-1415	123	10	,	,	PUNCT
gra-1415	123	11	h.	h.	PROPN
gra-1415	123	12	,	,	PUNCT
gra-1415	123	13	ideura	ideura	NOUN
gra-1415	123	14	,	,	PUNCT
gra-1415	123	15	t.	t.	PROPN
gra-1415	123	16	,	,	PUNCT
gra-1415	123	17	yasuda	yasuda	PROPN
gra-1415	123	18	,	,	PUNCT
gra-1415	123	19	g.	g.	PROPN
gra-1415	123	20	,	,	PUNCT
gra-1415	123	21	&	&	CCONJ
gra-1415	123	22	takahashashi	takahashashi	PROPN
gra-1415	123	23	,	,	PUNCT
gra-1415	123	24	k.	k.	PROPN
gra-1415	123	25	(	(	PUNCT
gra-1415	123	26	2007	2007	NUM
gra-1415	123	27	)	)	PUNCT
gra-1415	123	28	.	.	PUNCT
gra-1415	124	1	antiproteinuric	antiproteinuric	ADJ
gra-1415	124	2	effect	effect	NOUN
gra-1415	124	3	of	of	ADP
gra-1415	124	4	the	the	DET
gra-1415	124	5	calcium	calcium	NOUN
gra-1415	124	6	channel	channel	NOUN
gra-1415	124	7	blocker	blocker	NOUN
gra-1415	124	8	cilnidipine	cilnidipine	NOUN
gra-1415	124	9	added	add	VERB
gra-1415	124	10	to	to	ADP
gra-1415	124	11	rennin	rennin	NOUN
gra-1415	124	12	angiotensin	angiotensin	NOUN
gra-1415	124	13	inhibition	inhibition	NOUN
gra-1415	124	14	in	in	ADP
gra-1415	124	15	hypertensive	hypertensive	ADJ
gra-1415	124	16	patients	patient	NOUN
gra-1415	124	17	with	with	ADP
gra-1415	124	18	chronic	chronic	ADJ
gra-1415	124	19	renal	renal	ADJ
gra-1415	124	20	disease	disease	NOUN
gra-1415	124	21	.	.	PUNCT
gra-1415	125	1	kidney	kidney	NOUN
gra-1415	125	2	int	int	NOUN
gra-1415	125	3	,	,	PUNCT
gra-1415	125	4	72(2	72(2	NOUN
gra-1415	125	5	)	)	PUNCT
gra-1415	125	6	,	,	PUNCT
gra-1415	125	7	1543	1543	NUM
gra-1415	125	8	-	-	SYM
gra-1415	125	9	1549	1549	NUM
gra-1415	125	10	.	.	PUNCT
gra-1415	126	1	https://doi.org/	https://doi.org/	VERB
gra-1415	126	2	10.1038/	10.1038/	PROPN
gra-1415	126	3	sj.ki.5002623	sj.ki.5002623	NUM
gra-1415	126	4	12	12	NUM
gra-1415	126	5	.	.	PUNCT
gra-1415	127	1	uchida	uchida	PROPN
gra-1415	127	2	,	,	PUNCT
gra-1415	127	3	s.	s.	PROPN
gra-1415	127	4	,	,	PUNCT
gra-1415	127	5	takahashi	takahashi	PROPN
gra-1415	127	6	,	,	PUNCT
gra-1415	127	7	m.	m.	NOUN
gra-1415	127	8	,	,	PUNCT
gra-1415	127	9	sugawara	sugawara	NOUN
gra-1415	127	10	,	,	PUNCT
gra-1415	127	11	m.	m.	NOUN
gra-1415	127	12	,	,	PUNCT
gra-1415	127	13	saito	saito	PROPN
gra-1415	127	14	,	,	PUNCT
gra-1415	127	15	t.	t.	PROPN
gra-1415	127	16	,	,	PUNCT
gra-1415	127	17	nakai	nakai	PROPN
gra-1415	127	18	,	,	PUNCT
gra-1415	127	19	k.	k.	PROPN
gra-1415	127	20	,	,	PUNCT
gra-1415	127	21	fujita	fujita	PROPN
gra-1415	127	22	,	,	PUNCT
gra-1415	127	23	m.	m.	NOUN
gra-1415	127	24	,	,	PUNCT
gra-1415	127	25	mochizuki	mochizuki	PROPN
gra-1415	127	26	,	,	PUNCT
gra-1415	127	27	k.	k.	PROPN
gra-1415	127	28	,	,	PUNCT
gra-1415	127	29	shin	shin	PROPN
gra-1415	127	30	,	,	PUNCT
gra-1415	127	31	i.	i.	PROPN
gra-1415	127	32	,	,	PUNCT
gra-1415	127	33	morita	morita	PROPN
gra-1415	127	34	,	,	PUNCT
gra-1415	127	35	t.	t.	PROPN
gra-1415	127	36	,	,	PUNCT
gra-1415	127	37	hikita	hikita	NOUN
gra-1415	127	38	,	,	PUNCT
gra-1415	127	39	t.	t.	PROPN
gra-1415	127	40	,	,	PUNCT
gra-1415	127	41	itakura	itakura	PROPN
gra-1415	127	42	,	,	PUNCT
gra-1415	127	43	h.	h.	PROPN
gra-1415	127	44	,	,	PUNCT
gra-1415	127	45	takahashi	takahashi	PROPN
gra-1415	127	46	,	,	PUNCT
gra-1415	127	47	y.	y.	PROPN
gra-1415	127	48	,	,	PUNCT
gra-1415	127	49	mizuno	mizuno	PROPN
gra-1415	127	50	,	,	PUNCT
gra-1415	127	51	s.	s.	PROPN
gra-1415	127	52	,	,	PUNCT
gra-1415	127	53	ohno	ohno	PROPN
gra-1415	127	54	,	,	PUNCT
gra-1415	127	55	y.	y.	PROPN
gra-1415	127	56	,	,	PUNCT
gra-1415	127	57	ito	ito	PROPN
gra-1415	127	58	,	,	PUNCT
gra-1415	127	59	k.	k.	PROPN
gra-1415	127	60	,	,	PUNCT
gra-1415	127	61	ito	ito	PROPN
gra-1415	127	62	,	,	PUNCT
gra-1415	127	63	t.	t.	PROPN
gra-1415	127	64	,	,	PUNCT
gra-1415	127	65	&	&	CCONJ
gra-1415	127	66	soma	soma	PROPN
gra-1415	127	67	,	,	PUNCT
gra-1415	127	68	m.	m.	NOUN
gra-1415	127	69	(	(	PUNCT
gra-1415	127	70	2014	2014	NUM
gra-1415	127	71	)	)	PUNCT
gra-1415	127	72	.	.	PUNCT
gra-1415	128	1	effects	effect	NOUN
gra-1415	128	2	of	of	ADP
gra-1415	128	3	the	the	DET
gra-1415	128	4	n	n	CCONJ
gra-1415	128	5	/	/	SYM
gra-1415	128	6	l	l	NOUN
gra-1415	128	7	-	-	PUNCT
gra-1415	128	8	type	type	NOUN
gra-1415	128	9	calcium	calcium	NOUN
gra-1415	128	10	channel	channel	NOUN
gra-1415	128	11	blocker	blocker	NOUN
gra-1415	128	12	cilnidipine	cilnidipine	NOUN
gra-1415	128	13	on	on	ADP
gra-1415	128	14	nephropathy	nephropathy	NOUN
gra-1415	128	15	and	and	CCONJ
gra-1415	128	16	uric	uric	ADJ
gra-1415	128	17	acid	acid	NOUN
gra-1415	128	18	metabolism	metabolism	NOUN
gra-1415	128	19	in	in	ADP
gra-1415	128	20	hypertensive	hypertensive	ADJ
gra-1415	128	21	patients	patient	NOUN
gra-1415	128	22	with	with	ADP
gra-1415	128	23	chronic	chronic	ADJ
gra-1415	128	24	kidney	kidney	NOUN
gra-1415	128	25	disease	disease	NOUN
gra-1415	128	26	(	(	PUNCT
gra-1415	128	27	j	j	PROPN
gra-1415	128	28	-	-	PUNCT
gra-1415	128	29	circle	circle	NOUN
gra-1415	128	30	study	study	NOUN
gra-1415	128	31	)	)	PUNCT
gra-1415	128	32	.	.	PUNCT
gra-1415	129	1	j	j	PROPN
gra-1415	129	2	clin	clin	PROPN
gra-1415	129	3	hypertens	hyperten	VERB
gra-1415	129	4	(	(	PUNCT
gra-1415	129	5	greenwich	greenwich	PROPN
gra-1415	129	6	)	)	PUNCT
gra-1415	129	7	,	,	PUNCT
gra-1415	129	8	16(10	16(10	NOUN
gra-1415	129	9	)	)	PUNCT
gra-1415	129	10	,	,	PUNCT
gra-1415	129	11	746	746	NUM
gra-1415	129	12	-	-	SYM
gra-1415	129	13	753	753	NUM
gra-1415	129	14	.	.	PUNCT
gra-1415	130	1	https://doi.org/10.1111/jch.12412	https://doi.org/10.1111/jch.12412	ADJ
gra-1415	130	2	13	13	NUM
gra-1415	130	3	.	.	PUNCT
gra-1415	131	1	malleshappa	malleshappa	PROPN
gra-1415	131	2	,	,	PUNCT
gra-1415	131	3	p.	p.	NOUN
gra-1415	131	4	(	(	PUNCT
gra-1415	131	5	2013	2013	NUM
gra-1415	131	6	)	)	PUNCT
gra-1415	131	7	.	.	PUNCT
gra-1415	132	1	cilnidipine	cilnidipine	PROPN
gra-1415	132	2	effectively	effectively	ADV
gra-1415	132	3	reduces	reduce	VERB
gra-1415	132	4	low	low	ADJ
gra-1415	132	5	-	-	PUNCT
gra-1415	132	6	grade	grade	NOUN
gra-1415	132	7	albuminuria	albuminuria	NOUN
gra-1415	132	8	in	in	ADP
gra-1415	132	9	hypertensive	hypertensive	ADJ
gra-1415	132	10	chronic	chronic	ADJ
gra-1415	132	11	kidney	kidney	NOUN
gra-1415	132	12	disease	disease	NOUN
gra-1415	132	13	patients	patient	NOUN
gra-1415	132	14	.	.	PUNCT
gra-1415	133	1	dial	dial	PROPN
gra-1415	133	2	traspl	traspl	PROPN
gra-1415	133	3	,	,	PUNCT
gra-1415	133	4	34(1	34(1	NUM
gra-1415	133	5	)	)	PUNCT
gra-1415	133	6	,	,	PUNCT
gra-1415	133	7	2	2	NUM
gra-1415	133	8	-	-	SYM
gra-1415	133	9	6	6	NUM
gra-1415	133	10	.	.	PUNCT
gra-1415	133	11	https://doi.org/	https://doi.org/	VERB
gra-1415	133	12	10.1016	10.1016	NUM
gra-1415	133	13	/	/	SYM
gra-1415	133	14	j.dialis.2012.04.001	j.dialis.2012.04.001	PROPN
gra-1415	133	15	14	14	NUM
gra-1415	133	16	.	.	PUNCT
gra-1415	134	1	soeki	soeki	PROPN
gra-1415	134	2	,	,	PUNCT
gra-1415	134	3	t.	t.	PROPN
gra-1415	134	4	,	,	PUNCT
gra-1415	134	5	kitani	kitani	PROPN
gra-1415	134	6	,	,	PUNCT
gra-1415	134	7	m.	m.	NOUN
gra-1415	134	8	,	,	PUNCT
gra-1415	134	9	kusunose	kusunose	PROPN
gra-1415	134	10	,	,	PUNCT
gra-1415	134	11	k.	k.	PROPN
gra-1415	134	12	,	,	PUNCT
gra-1415	134	13	yagi	yagi	PROPN
gra-1415	134	14	,	,	PUNCT
gra-1415	134	15	s.	s.	PROPN
gra-1415	134	16	,	,	PUNCT
gra-1415	134	17	taketani	taketani	PROPN
gra-1415	134	18	,	,	PUNCT
gra-1415	134	19	y.	y.	PROPN
gra-1415	134	20	,	,	PUNCT
gra-1415	134	21	koshiba	koshiba	PROPN
gra-1415	134	22	,	,	PUNCT
gra-1415	134	23	k.	k.	PROPN
gra-1415	134	24	,	,	PUNCT
gra-1415	134	25	wakatsuki	wakatsuki	NOUN
gra-1415	134	26	,	,	PUNCT
gra-1415	134	27	t.	t.	PROPN
gra-1415	134	28	,	,	PUNCT
gra-1415	134	29	orino	orino	PROPN
gra-1415	134	30	,	,	PUNCT
gra-1415	134	31	s.	s.	PROPN
gra-1415	134	32	,	,	PUNCT
gra-1415	134	33	kawano	kawano	PROPN
gra-1415	134	34	,	,	PUNCT
gra-1415	134	35	k.	k.	PROPN
gra-1415	134	36	,	,	PUNCT
gra-1415	134	37	&	&	CCONJ
gra-1415	134	38	sata	sata	PROPN
gra-1415	134	39	,	,	PUNCT
gra-1415	134	40	m.	m.	NOUN
gra-1415	134	41	(	(	PUNCT
gra-1415	134	42	2012	2012	NUM
gra-1415	134	43	)	)	PUNCT
gra-1415	134	44	.	.	PUNCT
gra-1415	135	1	renoprotective	renoprotective	ADJ
gra-1415	135	2	and	and	CCONJ
gra-1415	135	3	antioxidant	antioxidant	ADJ
gra-1415	135	4	effects	effect	NOUN
gra-1415	135	5	of	of	ADP
gra-1415	135	6	cilnidipine	cilnidipine	NOUN
gra-1415	135	7	in	in	ADP
gra-1415	135	8	hypertensive	hypertensive	ADJ
gra-1415	135	9	patients	patient	NOUN
gra-1415	135	10	.	.	PUNCT
gra-1415	136	1	hypertens	hyperten	NOUN
gra-1415	136	2	res	res	PROPN
gra-1415	136	3	,	,	PUNCT
gra-1415	136	4	35(11	35(11	NUM
gra-1415	136	5	)	)	PUNCT
gra-1415	136	6	,	,	PUNCT
gra-1415	136	7	1058	1058	NUM
gra-1415	136	8	-	-	SYM
gra-1415	136	9	1062	1062	NUM
gra-1415	136	10	.	.	PUNCT
gra-1415	137	1	https://doi.org/10.1038/hr.2012.96	https://doi.org/10.1038/hr.2012.96	PROPN
gra-1415	137	2	15	15	NUM
gra-1415	137	3	.	.	PUNCT
gra-1415	138	1	kanaoka	kanaoka	PROPN
gra-1415	138	2	,	,	PUNCT
gra-1415	138	3	t.	t.	PROPN
gra-1415	138	4	,	,	PUNCT
gra-1415	138	5	tamura	tamura	PROPN
gra-1415	138	6	,	,	PUNCT
gra-1415	138	7	k.	k.	PROPN
gra-1415	138	8	,	,	PUNCT
gra-1415	138	9	wakui	wakui	PROPN
gra-1415	138	10	,	,	PUNCT
gra-1415	138	11	h.	h.	PROPN
gra-1415	138	12	,	,	PUNCT
gra-1415	138	13	ohsawa	ohsawa	PROPN
gra-1415	138	14	,	,	PUNCT
gra-1415	138	15	m.	m.	NOUN
gra-1415	138	16	,	,	PUNCT
gra-1415	138	17	azushima	azushima	PROPN
gra-1415	138	18	,	,	PUNCT
gra-1415	138	19	k.	k.	PROPN
gra-1415	138	20	,	,	PUNCT
gra-1415	138	21	uneda	uneda	NOUN
gra-1415	138	22	,	,	PUNCT
gra-1415	138	23	k.	k.	PROPN
gra-1415	138	24	,	,	PUNCT
gra-1415	138	25	kobayashi	kobayashi	PROPN
gra-1415	138	26	,	,	PUNCT
gra-1415	138	27	r.	r.	PROPN
gra-1415	138	28	,	,	PUNCT
gra-1415	138	29	fujikawa	fujikawa	PROPN
gra-1415	138	30	,	,	PUNCT
gra-1415	138	31	t.	t.	PROPN
gra-1415	138	32	,	,	PUNCT
gra-1415	138	33	tsurumi	tsurumi	NOUN
gra-1415	138	34	-	-	PUNCT
gra-1415	138	35	ikeya	ikeya	NOUN
gra-1415	138	36	,	,	PUNCT
gra-1415	138	37	y.	y.	PROPN
gra-1415	138	38	,	,	PUNCT
gra-1415	138	39	maeda	maeda	PROPN
gra-1415	138	40	,	,	PUNCT
gra-1415	138	41	a.	a.	PROPN
gra-1415	138	42	,	,	PUNCT
gra-1415	138	43	yanagi	yanagi	PROPN
gra-1415	138	44	,	,	PUNCT
gra-1415	138	45	m.	m.	NOUN
gra-1415	138	46	,	,	PUNCT
gra-1415	138	47	toya	toya	PROPN
gra-1415	138	48	,	,	PUNCT
gra-1415	138	49	y.	y.	PROPN
gra-1415	138	50	,	,	PUNCT
gra-1415	138	51	&	&	CCONJ
gra-1415	138	52	umemura	umemura	PROPN
gra-1415	138	53	,	,	PUNCT
gra-1415	138	54	s.	s.	PROPN
gra-1415	138	55	(	(	PUNCT
gra-1415	138	56	2013	2013	NUM
gra-1415	138	57	)	)	PUNCT
gra-1415	138	58	.	.	PUNCT
gra-1415	139	1	l	l	NOUN
gra-1415	139	2	/	/	SYM
gra-1415	139	3	n	n	CCONJ
gra-1415	139	4	-	-	PUNCT
gra-1415	139	5	type	type	NOUN
gra-1415	139	6	calcium	calcium	NOUN
gra-1415	139	7	channel	channel	NOUN
gra-1415	139	8	blocker	blocker	NOUN
gra-1415	139	9	cilnidipine	cilnidipine	NOUN
gra-1415	139	10	added	add	VERB
gra-1415	139	11	to	to	ADP
gra-1415	139	12	renin	renin	ADJ
gra-1415	139	13	-	-	PUNCT
gra-1415	139	14	angiotensin	angiotensin	NOUN
gra-1415	139	15	inhibition	inhibition	NOUN
gra-1415	139	16	improves	improve	VERB
gra-1415	139	17	ambulatory	ambulatory	ADJ
gra-1415	139	18	blood	blood	NOUN
gra-1415	139	19	pressure	pressure	NOUN
gra-1415	139	20	prole	prole	PROPN
gra-1415	139	21	and	and	CCONJ
gra-1415	139	22	suppresses	suppress	VERB
gra-1415	139	23	cardiac	cardiac	ADJ
gra-1415	139	24	hypertrophy	hypertrophy	NOUN
gra-1415	139	25	in	in	ADP
gra-1415	139	26	hypertension	hypertension	NOUN
gra-1415	139	27	with	with	ADP
gra-1415	139	28	chronic	chronic	ADJ
gra-1415	139	29	kidney	kidney	NOUN
gra-1415	139	30	disease	disease	NOUN
gra-1415	139	31	.	.	PUNCT
gra-1415	140	1	int	int	PROPN
gra-1415	140	2	j	j	PROPN
gra-1415	140	3	mol	mol	ADP
gra-1415	140	4	sci	sci	PROPN
gra-1415	140	5	,	,	PUNCT
gra-1415	140	6	14(8	14(8	NUM
gra-1415	140	7	)	)	PUNCT
gra-1415	140	8	,	,	PUNCT
gra-1415	140	9	16866	16866	NUM
gra-1415	140	10	-	-	SYM
gra-1415	140	11	16881	16881	NUM
gra-1415	140	12	.	.	PUNCT
gra-1415	141	1	https://doi.org/10.3390/ijms140816866	https://doi.org/10.3390/ijms140816866	PROPN
gra-1415	141	2	.	.	PUNCT
gra-1415	142	1	x	x	X
gra-1415	142	2	11gjra	11gjra	NUM
gra-1415	142	3	global	global	ADJ
gra-1415	142	4	journal	journal	PROPN
gra-1415	142	5	for	for	ADP
gra-1415	142	6	research	research	NOUN
gra-1415	142	7	analysis	analysis	NOUN
gra-1415	142	8	volume-9	volume-9	NUM
gra-1415	142	9	,	,	PUNCT
gra-1415	142	10	issue-1	issue-1	NUM
gra-1415	142	11	,	,	PUNCT
gra-1415	142	12	january-2020	january-2020	NOUN
gra-1415	142	13	•	•	NUM
gra-1415	142	14	print	print	NOUN
gra-1415	142	15	issn	issn	PROPN
gra-1415	142	16	no	no	NOUN
gra-1415	142	17	.	.	PROPN
gra-1415	142	18	2277	2277	NUM
gra-1415	142	19	8160	8160	NUM
gra-1415	142	20	•	•	NOUN
gra-1415	142	21	doi	doi	NOUN
gra-1415	142	22	:	:	PUNCT
gra-1415	142	23	10.36106	10.36106	NUM
gra-1415	142	24	/	/	SYM
gra-1415	142	25	gjra	gjra	NOUN